US20090138067A1 - Expandable supportive branched endoluminal grafts - Google Patents

Expandable supportive branched endoluminal grafts Download PDF

Info

Publication number
US20090138067A1
US20090138067A1 US11/906,703 US90670307A US2009138067A1 US 20090138067 A1 US20090138067 A1 US 20090138067A1 US 90670307 A US90670307 A US 90670307A US 2009138067 A1 US2009138067 A1 US 2009138067A1
Authority
US
United States
Prior art keywords
support
liner
expandable
graft
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/906,703
Inventor
Leonard Pinchuk
Rysler Alcime
Yasushi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeport Sciences LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/558,034 external-priority patent/US5639278A/en
Priority claimed from US08/863,964 external-priority patent/US5855598A/en
Application filed by Individual filed Critical Individual
Priority to US11/906,703 priority Critical patent/US20090138067A1/en
Assigned to CORVITA CORPORATION reassignment CORVITA CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ALCIME, RYSLER, KATO, YASUSHI, PINCHUK, LEONARD
Publication of US20090138067A1 publication Critical patent/US20090138067A1/en
Assigned to ACACIA RESEARCH GROUP LLC reassignment ACACIA RESEARCH GROUP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CORVITA CORPORATION
Assigned to LIFEPORT SCIENCES LLC reassignment LIFEPORT SCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACACIA RESEARCH GROUP LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A61F2/885Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils comprising a coil including a plurality of spiral or helical sections with alternate directions around a central axis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/826Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/001Figure-8-shaped, e.g. hourglass-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter

Definitions

  • This invention generally relates to supportive endoluminal grafts which have the ability to be delivered transluminally and expanded in place to provide a graft that is endoluminally positioned and placed, with the aid of an appropriate inserter or catheter, and that remains so placed in order to both repair a vessel defect and provide lasting support at the location of the graft.
  • the graft preferably combines into a single structure both an expandable luminal prosthesis tubular support component and a compliant graft component secured thereto.
  • the expandable supportive endoluminal graft takes on a bifurcated or branched structure made up of components that are designed to be positioned in a bifurcated manner with respect to each other, preferably during deployment or repair and support of vessel locations at or near branching sites.
  • the graft component is compliant, stretchable or elastomeric and does not substantially inhibit expansion of the tubular support component while simultaneously exhibiting porosity which facilitates normal cellular growth or invasion thereinto of tissue from the body passageway after implantation.
  • Elastomeric vascular grafts are known to be made by various methods. Included are methods which incorporate electrostatic spinning technology such as that described by Annis et al. in “An Elastomeric Vascular Prosthesis”, Trans. Am. Soc. Artif. Intern. Organs, Vol. XXIV, pages 209-214 (1978) and in U.S. Pat. No. 4,323,525.
  • a polymer such as a polyurethane in solution is extruded as fibers from a spinnerette onto a rotating mandrel.
  • the spinnerette system reciprocates along a path which is generally parallel to the longitudinal axis of the mandrel and at a controlled pitch angle. The result is a non-woven structure where each fiber layer is bound to the underlying fiber layer.
  • stent devices which are placed or implanted within a blood vessel or other body cavity or vessel for treating occlusions, stenoses, aneurysms, disease, damage or the like within the vessel. These stents are implanted within the vascular system or other system or body vessel to reinforce collapsing, partially occluded, weakened, diseased, damaged or abnormally dilated sections of the vessel. At times, stents are used to treat disease at or near a branch, bifurcation and/or anastomosis.
  • U.S. Pat. No. 4,140,126 describes a technique for positioning an elongated cylindrical stent at a region of an aneurysm to avoid catastrophic failure of the blood vessel wall, the stent being a cylinder that expands to an implanted configuration after insertion with the aid of a catheter.
  • Other such devices are illustrated in U.S. Pat. Nos. 4,787,899 and 5,104,399.
  • 4,503,569 and 4,512,338 show spring stents which expand to an implanted configuration with a change in temperature. It is implanted in a coiled configuration and then heated in place to cause the material of the spring to expand.
  • Spring-into-place stents are shown in U.S. Pat. No. 4,580,568.
  • U.S. Pat. No. 4,733,665 shows a number of stent configurations for implantation with the aid of a balloon catheter.
  • U.S. Pat. No. 5,019,090 shows a generally cylindrical stent formed from a wire that is bent into a series of tight turns and then spirally wound about a cylindrical mandrel to form the stent.
  • U.S. Pat. No. 4,994,071 describes a bifurcating stent having a plurality of wire loops that are interconnected by an elongated wire backbone and/or by wire connections and half hitches.
  • Stents themselves often do not encourage normal cellular invasion and can lead to undisciplined development of cells in the stent mesh, with rapid development of cellular hyperplasia. Grafts alone do not provide adequate support in certain instances.
  • Copending application of Jean-Pierre Dereume, Ser. No. 08/546,524, entitled “Luminal Graft Endoprostheses and Manufacture Thereof” describes grafts that have the ability to carry out dilatation and/or support functions.
  • An expandable tubular support component and an elastomeric graft component are combined into a single device wherein the graft material is secured to either or both of the internal and external surfaces of the expandable support component.
  • the graft material is produced by a spinning technique such as that described in U.S. Pat.
  • grafts which are expandable and supportive are provided that expand from a first diameter to a second diameter which is greater than the first.
  • the expandable supportive graft When it is at its first diameter, is of a size and shape suitable for insertion into the desired body passageway.
  • the material of the graft is substantially inert and preferably has a generally cylindrical cover and/or lining generally over the outside and/or inside surface of the expandable supportive component.
  • the cover and/or lining is especially advantageous because it is compliant or elastomeric and porous to encourage desirable growth of tissue thereinto in order to assist in non-rejecting securement into place and avoidance of stenosis development.
  • the porous liner and/or cover material is compliant or elastomeric enough to allow for expansion by up to about 2 to 4 times or more of its unexpanded diameter.
  • Components of the branched or bifurcated expandable supportive endoluminal graft preferably are deployable separately such that each component is properly positioned with respect to the other into the desired branched or bifurcated arrangement.
  • One of the components has a portion which has at least one longitudinally disposed indent to generally define at least two leg portions for receiving one of the other components.
  • Another object of this invention is to provide biocompatible grafts having a plurality of components that are separately expandable in vivo and that are supportive once so expanded.
  • Another object of the present invention is to provide an improved expandable reinforced graft that is delivered by way of introducers, balloon catheters or similar devices, and which facilitates good tissue ingrowth.
  • Another object of this invention is to provide an improved endoluminal graft which fully covers diseased or damaged areas for carrying out luminal repairs or treatments, such as repair of aneurysms.
  • Another object of the present invention is to provide an improved endoluminal graft wherein the endoprosthesis is substantially enclosed within biocompatible compliant material which is presented to the surrounding tissue and blood or other body fluid.
  • Another object of this invention is to provide an expandable, supportive graft that can be tailored to meet a variety of needs, including a single graft designed to address more than a single objective.
  • Another object of the present invention is to provide a self-expanding reinforced graft device that is delivered in its elongated and compressed state from within a tubular member and deployed by moving same out of the tubular member, which device is especially suitable for component deployment.
  • Another object of this invention is to provide a bifurcated trunk component that is deployed in a collapsed state and expanded in vivo to a branched device for use in treatment and/or repair at branched vessel locations.
  • a further object of the present invention is to provide a component branched endoluminal graft having a longitudinally creased trunk component and at least one cylindrical branch component, which components are expanded separately after endoluminal delivery and which form a bifurcated graft once positioned with respect to each other and expanded.
  • Another object of this invention is to provide an improved method of forming a branched endoluminal graft incorporating a longitudinal creasing procedure.
  • Another object of the present invention is to provide an improved method of assembling a branched endoluminal graft.
  • FIG. 1 is a perspective view, partially cut away, of an expandable supportive endoluminal graft construction in accordance with the invention
  • FIG. 2 is a cross-sectional view along the line 2 - 2 of FIG. 1 ;
  • FIG. 3 is a perspective view, partially cut away, of another embodiment of the expandable supportive endoluminal graft construction
  • FIG. 4 is a cross-sectional view along the line 4 - 4 of FIG. 3 ;
  • FIG. 5 is a perspective view, partially cut away, of a further embodiment of the expandable luminal graft construction
  • FIG. 6 is a cross-sectional view along the line 6 - 6 of FIG. 5 ;
  • FIG. 7 is a perspective view, partially cut away, of a bifurcated expandable supportive endoluminal graft construction
  • FIG. 8 is a cross-sectional view along the line 8 - 8 of FIG. 7 ;
  • FIG. 9 is a somewhat schematic view illustrating an early step in the implantation of a device such as shown in FIG. 7 ;
  • FIGS. 10 , 11 and 12 are generally schematic views along the lines of FIG. 9 showing expansion of the main body and the branches of this bifurcated device;
  • FIG. 13 shows this bifurcated supportive graft after completion of the expansion procedure
  • FIG. 14 illustrates another embodiment of a bifurcated expandable supportive endoluminal graft construction
  • FIGS. 15 , 16 and 17 illustrate implantation and assembly of the graft of FIG. 14 ;
  • FIGS. 18 , 19 , 20 and 21 illustrate a component branched graft and various stages of its separate, component deployment within a body vessel to repair an aneurysm, FIGS. 18 and 19 showing deployment of a preferred branched, longitudinally indented trunk component, and
  • FIGS. 20 and 21 showing separate deployment of two branch components within the trunk component
  • FIG. 22 is a top plan view of an embodiment of a branching trunk component in accordance with the invention.
  • FIG. 23 is a cross-sectional view along the line 23 - 23 of FIG. 22 ;
  • FIG. 24 is a side elevational view of the branching trunk component as illustrated in FIGS. 22 and 23 ;
  • FIG. 25 is an end view of the structure as shown in FIG. 24 ;
  • FIG. 26 is a perspective, generally exploded view of an example of a fixture suitable for forming the longitudinal crease in this trunk component
  • FIG. 27 is a longitudinal broken-away view of the fixture of FIG. 26 with a braided cylindrical tube positioned therein;
  • FIG. 28 is a view generally in accordance with FIG. 27 , showing formation of opposing crease indents in the braided cylindrical tube during formation of this trunk component;
  • FIG. 29 is a top plan view showing assembly of supportive endoprosthesis leg components into a branching trunk component according to the invention.
  • FIG. 30 is an end view of the structure as shown in FIG. 29 ;
  • FIG. 31 is a perspective view of another embodiment of a branching trunk component in accordance with the invention.
  • FIG. 32 is a cross-sectional view along the line 32 - 32 of FIG. 31 ;
  • FIG. 33 is a perspective view of a modified embodiment of a branching trunk component, having a section of enhanced hoop strength.
  • FIG. 1 An embodiment of expandable supportive luminal graft construction is generally illustrated in FIG. 1 at 21 .
  • This embodiment includes a braided tubular support component having generally helically wound rigid but flexible strand or wire elements, some of which have the same direction of winding but are axially displaced from one another, and others of which cross these windings and are also axially displaced with respect to each other.
  • the actual structure can be generally braided as illustrated in Wallsten U.S. Pat. No. 4,655,771, incorporated by reference hereinto, or as found in self-expanding braided flat wire Wallstent® devices.
  • Both a cover 23 and a liner 24 are illustrated in FIGS. 1 and 2 . Either cover 23 or liner 24 can be omitted if there is no desire to substantially encapsulate the tubular support component 22 .
  • cover 23 and liner 24 when included, they may be formed by an electrostatic spinning process in this illustrative embodiment. Details regarding electrostatic spinning techniques in general are found in Bornat U.S. Pat. No. 4,323,525 and in Bornat European patent publication No. 9,941, as well as in the Annis et al. article discussed hereinabove, the disclosures of which are incorporated by reference hereinto. With further reference to the application of this technology to the expandable supportable luminal grafts of the present invention, random pattern filaments are formed and electrostatically directed toward a charged mandrel in order to form a random pattern of electrostatically generally cross-linked filaments which take on the configuration of a mat having a cylindrical shape.
  • the filament diameters are particularly fine, as is the pore size of the mat so constructed.
  • a typical range of filament diameters is between about 0.5 micron and about 5 microns, and a typical pore size of the electrostatically spun fiber is between about 3 microns and about 20 microns.
  • Liner 24 is formed directly on the rotating mandrel by this electrostatic spinning procedure. Thereafter, one of the tubular support components discussed herein, such as the generally braided tubular support 22 , is placed over the liner 24 still on the mandrel. In the case of the tubular support 22 in a form that is not spring loaded, this includes longitudinally extending the tubular support 22 , such as by pulling one or both of its ends, which thereby decreases its diameter so that it fits snugly over the liner 24 . When the generally braided tubular support 22 is of a spring-into-place type, a hold-down member (such as shown in FIGS. 18 and 20 ) is used to prevent automatic radial expansion prior to deployment.
  • a hold-down member such as shown in FIGS. 18 and 20
  • the mandrel is again rotated, and the electrostatic spinning is again accomplished in order to form the cover 23 directly over the tubular support 22 .
  • This will also create some bonding between the thus formed cover 23 and the liner 24 at openings between the strands or wires of the woven tubular support 22 or the like.
  • This bonding can be facilitated by uniformly compressing the outer fibers with a soft silicone roller or sponge such that the still tacky outer fibers bond to the inner fibers thereby encapsulating the tubular support within the graft.
  • Bonding may also be achieved in this or other embodiments by heat welding and/or by the use of adhesives such as hot melt adhesives, primers, coupling agents, silicone adhesives, and the like, and combinations of these. Examples include aliphatic polycarbonate urethane hot melts and silicone rubber adhesives.
  • each of the cover 23 and the liner 24 when either or both are present, is made of an elastomeric material which retains its compliant properties after construction of the expandable supportive graft 21 is completed.
  • the graft itself is also elastomeric and compliant. Accordingly, the graft 21 is delivered transluminally, such as by being pulled down onto the balloon of a catheter or into an inserter tube and then percutaneously inserted and positioned to the location where the repair is needed. For a non-spring loaded graft, the balloon is then inflated to longitudinally shorten and radially expand the graft 21 into engagement with the vessel walls.
  • the graft 21 will remain in place.
  • ends 25 of the tubular support are exposed and are not covered by the cover 23 . This allows the exposed end portions 25 to directly engage the vessel wall, if desired in the particular application, in order to assist in anchoring the graft 21 in place.
  • Liner 24 also can be sized so as to not cover the exposed ends 25 , or it can extend to or beyond the edge of the ends 25 when it is desired to avoid or minimize contact between the tubular support and the blood or other fluid flowing through the vessel being repaired or treated.
  • transluminal delivery can be made by way of a catheter or tool having means for longitudinally compressing the endoprosthesis until it has expanded radially to the desired implanted diameter.
  • a catheter or tool having means for longitudinally compressing the endoprosthesis until it has expanded radially to the desired implanted diameter.
  • Such equipment typically includes a member that engages one end of the endoprosthesis and another member which engages the other end of the endoprosthesis. Manipulation of proximally located controls then effects relative movement of the members toward each other in order to thereby longitudinally compress the endoprosthesis.
  • Delivery tools for spring-loaded grafts include a sleeve that maintains the graft at its compressed diameter until the graft is positioned for deployment such as from the end of an insertion catheter to its auto-expanded state.
  • an expandable supportive graft is illustrated at 31 .
  • the illustrated tubular support component 32 is constructed of sinusoidally configured wire helically wound into a tubular shape. General structures of these types are generally discussed in Pinchuk U.S. Pat. No. 5,019,090, incorporated by reference hereinto.
  • a cover 33 can be positioned over the tubular support 32 and/or a liner 34 can be positioned along its lumen.
  • the cover 33 and liner 34 are constructed of porous polymers, the pores thereof having been made by elution or extraction of salts and the like, such as described in MacGregor U.S. Pat. No. 4,459,252, incorporated by reference hereinto.
  • the porosity is determined by the size of the elutable particles as discussed herein and by the concentration of those particles as a percent by volume of a pre-elution mixture thereof with the polymer of the cover or liner.
  • a mandrel or rod is dipped into a liquid polymer having elutable particles as discussed herein dispersed therewithin.
  • the polymer covered rod is contacted with, such as by dipping or spraying, a solvent, for the elutable particles, such as water, thereby forming the eluted porous liner 34 .
  • the tubular support 32 is positioned thereover and pressed down into the liner.
  • the rod and the assembly thereon are again dipped into the mixture of polymer and elutable particles, followed by setting and contact with solvent to remove the elutable particles in order to form the eluted porous cover 33 . It is also possible to directly extrude the particle-containing polymer into a tubular shape.
  • Elutable particles which can be used in the making of the eluted porous cover 33 and liner 34 include salts such as sodium chloride crystals, sodium carbonate, calcium fluoride, magnesium sulfate and other water-soluble materials that are readily dissolved by the utilization of water as an elution medium. Other particles that are soluble in organic solvents and the like can be substituted as desired. Further particles include sugars, proteins, and water-soluble hydrogels such as polyvinyl pyrrolidone and polyvinyl alcohol. Suitable polymer materials are as discussed elsewhere herein, the pore size being on the order of about 10 microns to about 80 microns.
  • ends 35 of the support component 32 can be exposed either on one or both of its cylindrical faces in accordance with the needs of the particular repair or treatment to be carried out.
  • the exposed ends 35 will assist in maintaining the graft 32 in place by mechanical engagement between the exposed ends 35 and the vessel being repaired or treated and/or by tissue ingrowth.
  • the anchoring aspect of the exposed ends of the tubular support can be enhanced by continued radial expansion of the balloon or other deployment means which will permit the exposed ends to expand radially outwardly in an amount somewhat greater than that of the rest of the expandable supportive graft and into the surrounding tissue.
  • mechanical means can be used to assist in joining the exposed ends of this embodiment or of other embodiments to the vessel wall.
  • transluminally delivered staples which can take on the appearance of rivets.
  • staples made of an elastomeric material Illustrated staples are shown at 36 in FIG. 3 . They can be incorporated at other locations as well along the graft.
  • One or more windows 37 can be formed through the cover and/or liner and/or tubular support in order to feed outside branch arteries or other vessels.
  • FIGS. 5 and 6 illustrate a further embodiment of an expandable supported graft, generally designated as 41 .
  • a mesh tubular support component generally designated as 42 , such as those of the type illustrated in Palmaz U.S. Pat. No. 4,733,665, incorporated by reference hereinto.
  • These are non-woven mesh-type cylinders or slotted tubes wherein most or all of the individual components are either integrally joined together such as by welding or are integrally formed from a single tube.
  • the resulting endoprostheses are malleable enough so as to be expandable by a balloon of a catheter. Usually, these endoprostheses have particularly high hoop strengths.
  • Cover 43 and/or liner 44 are made of polymers rendered porous by phase inversion techniques.
  • a polymer such as a polyurethane is dissolved in a solvent therefor, for example a water-soluble polar solvent, such as dimethyl acetamide, tetrahydrofuran and the like, in order to form what is known as a lacquer.
  • a mandrel or rod is dipped into the lacquer. Thereafter, the dipped rod is contacted with an inversion solvent, such as by dipping in water or a mixture of alcohol and water.
  • This inversion solvent must readily dissolve the polymer solvent of the lacquer, while at the same time being a poor solvent for the polymer.
  • the polymer coagulates and the polymer solvent of the lacquer is removed and replaced with the inversion solvent.
  • the inversion solvent pulls the polymer solvent out of the polymer on the rod and forms particularly fine pores having a pore size on the order of about 0.5 micron to about 20 microns.
  • the thus formed liner 44 having phase inversion pores is then dried.
  • the tubular support component 42 is secured over the liner 44 and is preferably radially compressed onto and into the liner.
  • the cover 43 having phase inversion pores is formed in accordance with the same phase inversion steps as discussed hereinabove for preparation of the liner 44 . If desired, either the liner or the cover can be omitted.
  • Cover 43 and liner 44 are thus formed in accordance with a displacing step wherein precipitating non-solvent molecules are substituted for non-precipitating solvent molecules dispersed throughout the lacquer coating. This procedure develops advantageous elastic characteristics. Further details regarding the phase inversion procedure are found in Lymann et al. U.S. Pat. No. 4,173,689, incorporated by reference hereinto.
  • FIGS. 7 and 8 illustrate an embodiment wherein the graft takes the form of a bifurcated expandable supportive graft, generally designated at 51 . Included is a joined-ring bifurcated tubular support 52 . Also shown are a bifurcated cover 53 , a bifurcated lining 54 and exposed ends 55 , 56 , 57 . This particular bifurcating graft is well-suited for insertion into a branching vessel.
  • the tubular support includes a plurality of rings or loops 58 connected by flexible interconnections 59 . Constructional details of embodiments of the rings or loops 58 and of the flexible interconnections 59 are found in MacGregor U.S. Pat. No. 4,994,071, incorporated by reference hereinto.
  • the flexible interconnections 59 join the rings or loops 58 into a configuration having a main body or trunk 61 and one or more branches 62 .
  • Flexible interconnections 59 extend longitudinally from the axis of each of the main body or trunk 61 and branch 62 , 63 . At least one such flexible interconnection joins each branch to the trunk.
  • the loops 58 in the main body are substantially parallel to each other, and the loops 58 in each branch 62 , 63 are substantially parallel to each other.
  • the bifurcated cover 53 and bifurcated liner 54 must each, when provided, be especially elastomeric so as to follow the expansion and contraction of the rings or loops 58 that takes place during preparation, transluminal insertion, deployment and the like.
  • Cover 53 and liner 54 will also take on a bifurcated construction.
  • the liner and/or cover for each of the trunk 61 and branch 62 , 63 are made on a cylindrical mandrel, assembled and joined, such as by suitable biocompatible adhesive, fusion, sewing, suturing or other means of joining and/or sealing.
  • a Y-shaped or branched mandrel can be used.
  • bifurcating liner is then formed thereon by processes such as those discussed herein, including electrostatic spinning, or dipping followed by elution or phase inversion procedures much in the same manner as described herein when straight cylindrical mandrels or rods are used for constructing the non-bifurcated grafts in accordance with this invention. Fiber winding can also be practiced.
  • Bifurcated cover 53 is made in a similar manner by application of the porous cover material over the bifurcated endoprosthesis.
  • the bifurcated cover 53 and/or bifurcated liner 54 could be made by fiber winding approaches, such as those described in Wong U.S. Pat. No. 4,475,972, the subject matter thereof being incorporated by reference hereinto.
  • Polymer in solution is extruded into fibers from a spinnerette onto a rotating mandrel.
  • the spinnerette is reciprocated along the longitudinal axis of the mandrel at a controlled pitch angle, resulting in a non-woven cylinder wherein each fiber layer is bound to the underlying layer. Control of the pitch angle allows for control of the compliance and kink resistance of the cover and/or liner.
  • the cover is physically bonded to the liner by the use of an electrostatic field to enable penetration of the cover overlay of fibers through the interstices of the support components in order to improve the bonding of the cover and/or liner fibers to each other and/or to surfaces of the support component.
  • FIGS. 9 , 10 , 11 , 12 and 13 With more particular reference to balloon deployment of expandable supportive grafts, this is illustrated with some particularity in connection with bifurcated endoluminal grafts in FIGS. 9 , 10 , 11 , 12 and 13 .
  • two guidewires 64 , 65 are inserted into the bifurcating vessel, each of them into different legs 66 , 67 of the bifurcating vessel.
  • the unexpanded bifurcated expandable supportive graft 51 is slipped over the proximal ends of the guidewires and routed to the branches of the blood vessel.
  • the unexpanded bifurcated graft can be introduced from an arteriotomy proximal to the bifurcation such as from the brachial artery in the arm, or the unexpanded bifurcated graft can be introduced from the femoral artery in the leg, pushed proximally past the bifurcation and then pulled back distally into both iliacs to form the trunk and bifurcation.
  • the two branches 62 , 63 of the graft 51 are routed separately over the guidewires 64 , 65 , respectively, and guided, typically with the help of a guide catheter, into the patient until the graft is positioned as shown in FIG. 9 .
  • the graft 51 is initially fixed in place as follows. One of the guidewires 65 is removed, and a balloon catheter 68 is inserted into the main body or trunk 61 and inflated to expand the trunk 61 into contact with the vessel walls. This deployment is suitable to secure the graft 51 in place at that location of the vessel.
  • the balloon of balloon catheter 68 is then deflated. If this balloon catheter is also suitable for use in expanding the branches 62 , 63 of the graft 51 , same is then inserted into an unexpanded branch 62 and radially expanded as generally shown in FIG. 11 . If the balloon of catheter 68 is not suitable in this regard, then another balloon catheter 69 effects this function.
  • FIG. 12 shows inflation of the other branch 63 of the graft 51 in a similar manner.
  • FIG. 13 illustrates the fully deployed and expanded bifurcated support graft 51 positioned in place within the bifurcated location.
  • a bifurcated dilation balloon on a bifurcated catheter can replace the single-balloon catheter(s) 68 , 69 .
  • the branched and assembled expandable supportive graft is of the spring-into-place type; as such, it will be manipulated to be reduced in diameter and placed within an overlying and bifurcated restraining guiding catheter or the like and will be passed over guidewires and contained within the guiding catheter until proper placement within the bifurcating location.
  • This type of bifurcated expandable supportive graft is deployed by being ejected into place, typically by advancing a small inner catheter through the guiding catheter into contact with the bifurcating graft in accordance with the procedure generally used for spring-into-place stents.
  • FIGS. 9 through 13 can be characterized as prograde deployment. Retrograde deployment is also possible.
  • the entire bifurcating graft for retrograde deployment is advanced over a single guidewire through one branch of the blood vessel past the point of bifurcation.
  • a second guidewire is then steered down the opposite limb of the graft, and a snare is used.
  • the snare which is passed retrograde through the opposite vessel, is then used to pull the guidewire into place.
  • Partial balloon inflation in the unbranched or trunk portion of the blood vessel is then used to draw the graft down into position prior to balloon dilatation of both the trunk and branched portions of the graft.
  • the contact between the bifurcation of the graft and the bifurcation of the blood vessel helps to prevent the graft from migrating distally, thus reducing the need for active fixation of the graft to the blood vessel.
  • FIG. 14 Another bifurcated endoprosthesis or expandable supportive graft is generally designated 81 in FIG. 14 .
  • tubular supporting component(s) are, prior to deployment, separate from a trunk component.
  • a fully independent tubular supporting component 82 is located at the trunk position of the graft 81 .
  • a bifurcated stretchable wall 83 is in contact with the independent tubular supporting component 82 as either or both of a cover or liner.
  • the stretchable wall 83 includes at least two generally tubular stretchable branch sleeves 85 , 86 which are initially devoid of a supporting component.
  • Separate tubular supporting components 87 , 88 are also included.
  • FIGS. 14 , 15 , 16 and 17 Implantation of this bifurcated expandable supportive graft is depicted in FIGS. 14 , 15 , 16 and 17 .
  • Dual guidewires 64 , 65 can be used to properly position the unexpanded bifurcated graft 81 within the bifurcating vessel as shown in FIG. 14 .
  • a balloon catheter 68 or similarly functioning device is inserted into the main body of the device so as to expand the independent tubular supporting component 82 and the trunk portion 84 of the bifurcated stretchable wall 83 .
  • This deployment initially secures the bifurcated supporting graft into place at that location of the vessel, as shown in FIG. 15 .
  • the balloon catheter is then deflated and removed or positioned for use in the next step.
  • a suitable balloon catheter 69 or the like is next used to deploy and expand in place a branch tubular expandable supporting component 89 , as illustrated in FIG. 16 .
  • a similar step deploys and expands in place another branch tubular expandable supporting component 90 , as generally shown in FIG. 17 .
  • the bifurcated stretchable wall 83 and the expandable supporting components may be made with the materials and constructions discussed herein and may be subjected to various treatments as discussed.
  • a further bifurcated endoprosthesis or expandable supportive graft is one in which the separate components are each expandable supportive graft members. These separate components are illustrated in FIG. 18 through FIG. 21 , which also illustrate their separate deployment with respect to each other within an aortic trunk. Same is shown in connection with treating an aneurysm such as an abdominal aorto-iliac aneurysm.
  • the device includes a trunk component 101 which, in the illustrated use, is designed to extend from below the renal arteries to a location between the proximal neck of the aneurysm and the aorto-iliac bifurcation.
  • this trunk component could also be shorter so that it terminates just below the proximal neck of the aneurysm, for example of a length which terminates within the dent or crease 124 .
  • the component bifurcated expandable supportive graft of this embodiment is self-expanding and is deployed by means of an introducer containing compressed expandable supportive graft components.
  • a guidewire 102 is first inserted in accordance with known procedures so as to traverse the aneurysm 103 .
  • an introducer generally designed as 104 having the trunk component therewithin in a radially compressed state is inserted over the guidewire 102 .
  • the introducer is maneuvered such that it is properly positioned as desired, in this case at a location distal of the distal end of the aneurysm.
  • the sheath 105 of the introducer is withdrawn, such as by sliding it in a proximal direction while the remainder of the introducer 104 remains in place.
  • the trunk 101 expands, eventually achieving the deployed or implanted position shown in FIG. 19 .
  • the distal portion 106 of the trunk is well anchored into the blood vessel wall and is suitably deployed.
  • FIG. 20 shows an introducer, generally designated as 107 , having an independent tubular expandable supportive graft leg component 108 ( FIG. 21 ) radially compressed therewithin.
  • this leg component is an iliac component of the bifurcated supportive graft being assembled within the body vessel.
  • the introducer 107 is advanced until this iliac component is moved into a leg 109 of the already deployed trunk component 101 . This positioning is illustrated in FIG. 21 .
  • the iliac tubular supportive graft component 108 extends from well within the leg 109 to a location proximal of the aneurysm in the iliac artery 110 .
  • trunk component 101 and the tubular components 108 , 115 are generally telescopically positioned with respect to each other.
  • This telescopic feature allows some slippage between the trunk component and the tubular leg components, thereby providing a telescopic joint which functions as a slip bearing.
  • FIGS. 22 , 23 , 24 and 25 further illustrate a trunk component 101 . It includes a common trunk portion 118 and a branched portion, generally designated as 119 .
  • the branched portion includes the legs 109 and 113 .
  • a further common trunk portion 120 is located opposite the other common trunk portion 118 and extending from the branched portion 119 .
  • the overall configuration of the trunk component is that of a double-lumen length located between two single-lumen lengths.
  • the common trunk portion 118 can be positioned, for example, in the aortic artery, the branched portion 119 provides a bifurcation structure to direct blood flow into the two iliac arteries, and the further common trunk portion 120 facilitates deployment of the leg components into the branched portion 119 , acting in the nature of a funnel for each guidewire, introducer and contracted leg component.
  • Trunk component 101 includes a stent or tubular supporting component 121 . Also included is a liner, generally designated as 122 . A further liner 123 preferably is located interiorly of the liner 122 . Liners 122 , 123 are secured within the stent component 121 in order to provide proper porosity for an endoprosthesis.
  • Trunk component 101 includes one or more indents, such as indent 124 and indent 125 .
  • a third, a fourth, or further indents can be provided depending upon the degree of branching desired.
  • one or more tubular expandable supportive leg graft components will be provided in order to slide into the branched passageways which are thus defined by the indent(s).
  • one such leg component 108 slidingly engages an opening 126 of the trunk component leg 109
  • a second leg component 115 slidingly and expansively fits within opening 127 of the leg component 115 .
  • this shows a trunk component 101 c which has a function and a configuration along the lines of trunk component 101 , except only the liner defines the indent or indents.
  • the tubular supporting component is cylindrical in cross-section substantially throughout its length.
  • FIG. 31 illustrates the trunk component 101 c . It includes a common trunk portion 118 c and a branched portion, generally designated as 119 c .
  • the bifurcated or branched portion includes the legs 109 c and 113 c .
  • a further common trunk portion 120 c is located opposite the other common trunk portion 118 c and extends from the branched or bifurcated portion 119 c .
  • the overall configuration of trunk component 101 c is that of a double-lumen length located between two single-lumen lengths.
  • Trunk component 101 c includes a stent or tubular supporting component 121 c , as perhaps best seen in FIG. 32 . Also included is a liner, generally designated as 122 c . This liner 122 c has a body portion 123 c and the legs 109 c and 113 c which open into another body portion 151 .
  • Each leg 109 c , 113 c is secured to the generally tubular stent component 121 c at outside portions thereof, particularly at adhesion zones 124 c and 125 c .
  • the remainder of the leg portions 109 c and 113 c are not so bonded to the stent portion 121 c .
  • This facilitates formation of the leg portions, which are typically pinched along the length of the legs in order to form at least one internal seam 126 c .
  • Leg openings 127 c and 128 c are thereby generally defined between this seam 126 c and the adhesion zones 124 c and 125 c.
  • a stent component 129 d is included which has a substantially higher pitch angle (for example, between about 140° and 180°) than does the stent portion 121 d therebelow within which the legs are positioned (for example, at a pitch angle of between about 70° and 90°). This higher pitch angle zone imparts a greater hoop strength upon deployment than does the stent 121 c of the trunk component 101 c .
  • a barb 130 is also shown in order to further assist in securement of the endoprosthesis to the artery wall.
  • the barb-type of structure can be a backing ring and barb formed out of the stent strand during its formation into the cylindrical supportive member.
  • any of the various expandable supportive endoluminal graft, or stent graft, constructions discussed or referred to herein can be used in order to construct devices in accordance with this embodiment. Other modifications may also be incorporated, including tubes having stepped diameters or conical ends.
  • the stent component can be made with flat wires or with pairs of wires or multifilament wires. They can incorporate balloon expandable stents, self-expanding stents, and combinations of balloon expandable stents and self-expanding stents. Use can be made of ancillary equipment such as endoluminal stapling devices or suturing devices in order to facilitate securement at the aneurysm neck, for example.
  • a portion of the stent component without a liner component or the like thereon can project at the proximal end of the endoluminal component, such as at a location which would be above the renal arteries.
  • the objective is also to help to secure the device in place.
  • the prosthesis as discussed is deployed to replace or repair tubular bodies such as blood vessels, tracheas, ureters and the like, accommodating more than one conduit in order to divert flow to other branches of the tubular body. This allows for repair of a bifurcated area which is difficult to repair using a single-lumen device or a plurality of individual single-lumen devices. It is suitable for repair of damages to branched conduits or, conversely, to repair conduits which converge into a single branch.
  • a preferred use for the bifurcating endoluminal grafts discussed herein is for insertion into a branching blood vessel. Same is typically suitable for use in the coronary vasculature (the right, left common, left anterior descending, and circumflex coronary arteries and their branches) and the peripheral vasculature (branches of the carotid, aorta, femoral, popliteal arteries and the like). These bifurcated devices are also suitable for implantation into other branching vessels such as in the gastrointestinal system, the tracheobronchial tree, the biliary system, and the genitourinary system.
  • the expandable supportive grafts in accordance with the present invention will dilate and/or support blood vessel lesions and other defects or diseased areas, including at or in proximity to sites of vascular bifurcations, branches and/or anastomoses.
  • the expandable supportive graft is an integral structure that incorporates the expandable support component into the wall or walls of the elastomeric graft. Covers and/or linings that make up the grafts interface with body components that facilitate normal cellular invasion without stenosis or recurrent stenosis when the graft is in its expanded, supportive orientation.
  • the graft material is inert and biocompatible.
  • the expandable supportive graft can be expanded from a smaller diameter insertion configuration to a larger diameter implantation configuration by the application of radially outwardly directed forces provided by expanding the endoprosthesis with a balloon catheter, using an ejection tube that allows a spring-into-place structure to be deployed from the end of a catheter into its expanded configuration, or by using a support component made of certain alloys exhibiting thermotransition characteristics by which they expand when heated, for example.
  • support structures include others having spring characteristics and those having a coil with circumferentially oriented fingers such as shown in Gianturco U.S. Pat. No. 4,800,882, incorporated by reference hereinto.
  • U.S. Pat. Nos. 5,061,275, 5,219,355 and 5,336,500 relate to expanding or self-expanding endoluminal devices. Typically, these devices center on the use of a metallic structure imparting expansion attributes.
  • U.S. Pat. Nos. 4,994,071 and 5,360,443 describe bifurcated devices which use expandable metallic stent structures and textile materials allowing branching of fluid flow. In general, materials of these patents, incorporated by reference hereinto, can be utilized in constructing components of the present invention.
  • the tubular supportive component preferably is a braided tubular stent body made of metal alloy or any other material that is flexible, while being rigid and resilient when thus braided.
  • Spring-type metals are typically preferred, such as stainless steel, titanium, stainless steel alloys, cobalt-chromium alloys, including alloys such as Elgiloy, Phynox and Conichrome.
  • Thermal transition or memory function alloys such as nickel-titanium alloys including Nitinol are also suitable.
  • Malleable metals including tantalum would be especially suitable for a structure that is not self-expanding.
  • the materials for the liner(s) are typically polymeric materials in the form of a membrane or textile-like material, the objective being to reduce the porosity of the stent for proper tissue ingrowth and fluid tightness.
  • Exemplary polymeric materials include polyesters such as polyethylene terephthalate, polyolefins such as polypropylene, or elastomeric materials such as polyurethane or silicone rubber. Combinations of these materials are also possible.
  • the exterior liner which engages the tubular supportive component 121 when provided, is made of a double tricot polyester mesh knit, typically a Dacron type of material, while the interior liner 122 c is made of a polyurethane.
  • a thin coating or cover of polymer is provided over the braided wires of the tubular supportive component.
  • the material must be stretchable with respect to the support component so that it will follow the movement of the endoprosthesis between its fully collapsed and expanded or implanted configurations.
  • Polyurethanes are preferred. Particularly preferred is an especially crack-resistant, elastomeric and pliable polycarbonate urethane as described in Pinchuk U.S. Pat. Nos. 5,133,742 and 5,229,431, incorporated by reference hereinto.
  • various surface treatments can be applied to render the surfaces of the expandable supported graft more biocompatible. Included are the use of pyrolytic carbon, hydrogels and the like. The surface treatments can also provide for the elution or immobilization of drugs such as heparin, antiplatelet agents, antiplatelet-derived growth factors, antibiotics, steroids, and the like. Additionally, the coating and/or liner can be loaded with drugs such as those discussed herein, as well as lytic agents in order to provide local drug therapy.
  • the indent(s) such as indents 124 , 125 and the seams(s) such as internal seam 126 c are longitudinally disposed and generally define at least two leg portions, each with a diameter less than the diameter of the main body.
  • Each indent has an internal longitudinal surface such as longitudinal edge 128 , 129 . These edges can be in contact with one another. If desired, they can be secured together such as with sutures, adhesives, wires, clips or the like (not shown).
  • One or two such indents or creases produce an asymmetrical or a symmetrical bifurcation as desired. In another exemplary approach, three indents would form a trifurcated device. Additional creases can be provided insofar as is allowable by the braided wire mesh density and diameter.
  • Seam 126 c can be formed by joining together two or more longitudinal portions of the liner 122 c . When two such longitudinal portions are joined together, they are generally opposite to each other. When three such longitudinal portions are joined together, they are approximately 120° from each other along the circumference of the liner 122 c , and three legs are formed. When four such longitudinal portions are joined together, for example, they are spaced approximately 90° apart.
  • the deformation of the braided tubular body reduces the cross-sectional area from that of the main trunk body to that of each branched area.
  • the total cross-sectional area of the branching tubular bodies should be equal to or greater than 40% of the cross-sectional area of the main trunk body. Preferably, this area should be greater than about 70% in order to prevent any significant pressure differences along the device once deployed and implanted.
  • the cross-sectional area of the abdominal aorta is reduced by only about 20% when opening into the common iliac arteries.
  • FIG. 26 illustrates a fixture suitable for use in forming the indent or indents as permanent deformations of the braided mesh cylinder which is the tubular supportive component for this embodiment.
  • Fixture 131 in the configuration as illustrated is used for shaping a symmetrical bifurcated design.
  • the braided cylinder is longitudinally compressed and placed over the mandrel 132 , this placement being generally shown in FIG. 27 .
  • End caps 133 , 134 lock the tubular supportive component 121 in its compressed state. Same is then placed into the fixture 131 , as generally shown in FIG. 26 .
  • Slits 135 are positioned parallel to the longitudinal axis and on opposite sides.
  • the length of the blade edges 138 , 139 can be varied in order to create a desired length of deformation on the main body of the trunk component.
  • branching areas thus formed can be made of different sizes by varying the size of the individual cylindrical components of the mandrel 132 so they are not identical as shown in FIG. 26 .
  • a larger sized mandrel cylinder will result in the formation of a larger trunk component leg 109 , 113 .
  • the trifurcated arrangement is achieved by a three-component mandrel and three slits and blades that are 120° apart.
  • a four-branched structure would include four of each features, spaced 90° apart.
  • the thus deformed braided tubular supportive component is chemically and heat processed in order to set the desired diameter and mechanical properties of the main body.
  • this flexible metallic stent with conformed shape is thus prepared, it is preferably lined as discussed elsewhere herein.
  • the illustrated tubular braided mesh has a main cross-sectional area and has an outward flair at both ends.
  • the braided structure is advantageously accommodated by the serrated structure of the blade edges 138 , 139 in that the wire elements of the braid are grasped and secured at the ends of the bifurcation.
  • the expandable supportive graft of the present invention is capable of being tailored to meet specific needs, depending upon the particular defect or disease being addressed, such as occlusion, stenosis, aneurysm, arteriovenosis fistula, trauma and the like, as well as upon the anatomy of the vessel.
  • the bifurcated graft of FIGS. 7 and 8 shows some separation along the support component, such as between the trunk 61 and the branches 62 , 63 .
  • grafts in accordance with the present invention it is also possible, with the grafts in accordance with the present invention, to provide an expandable graft having its supportive property emanating from one or more support components, while thereby providing an adjoining graft cylindrical portion which is supported primarily by its close proximity to a support component which can be presented at one end, both ends, or spaced along the expandable supportive graft in accordance with the invention.
  • FIG. 5 Such a structure is generally illustrated in FIG. 5 , wherein an adjoining graft cylindrical portion 71 is positioned between a first support component 72 and another or second support component 73 .
  • the expandable supportive graft in accordance with the present invention provides the tailorability advantage of being able to vary within a single graft the configuration, structure and properties of the support component or components of the graft. These various properties allow the expandable supportive graft to be tailored in accordance with particular needs of the disease, defect or damage being treated. For example, support may be particularly desirable at one location being treated, while a less rigid supportive area is needed at another, generally adjoining location.
  • a single graft can be deployed in order to effect two or more different functions.
  • the present invention reduces the risk of compromising the patency of the passageways being treated. This is particularly true in treating lesions at or near vascular bifurcations, branches and/or anastomoses.
  • Typical difficulties which can be avoided by the present invention include displacing of diseased tissue, vessel spasm, dissection with or without intimal flaps, thrombosis, embolism, and the like.
  • Another suitable use is for dilating and/or supporting vascular graft bifurcations and the like. Additionally, lesions affecting vascular trifurcations can be treated.
  • obstructed openings characterized by exaggerated cicatrization, abnormal cellular growth (subintimal fibromuscular hyperplasia and the like) or arterial or venous stenosis.
  • these supportive grafts can be used to reinforce vascular walls, weakened by pathological processes, for example, by dissection, as in the case of aneurysms.
  • the grafts can also obliterate congenital or acquired arteriovenous communications, and they can be applied in intrahepatic portal-caval shunts.
  • the grafts also can maintain biological pathways open, such as the digestive, biliary, pancreatic and urinary tracts, and they help to limit the intraluminal growth of pathological processes such as fibrosis or cancer.
  • This example illustrates the formation of a branched expandable supportive endoluminal graft having an expanded internal diameter of 10 mm and which is bifurcated to accommodate two endoluminal supportive graft legs of 5 to 7 mm in diameter.
  • a liner of non-woven polycarbonate urethane (Corethane®) was spun by winding over a mandrel, generally in accordance with U.S. Pat. No. 4,475,972. In this instance, the liner consisted of approximately 400 layers of fibers.
  • a bifurcated braided mesh tubular supportive component made in a fixture as illustrated in FIG. 26 was spray coated using a dilute solution of polycarbonate urethane having a hardness grade and a melting point lower than that used to spin the liner. It was allowed to dry with warm air. Several spray coats allow for the formation of an adhesive layer.
  • the previously prepared polycarbonate urethane liner was cut to length and placed inside the adhesive-coated bifurcated braided mesh and seated to closely fit the bifurcated braided mesh.
  • a mandrel having a shape similar to the inner configuration of the bifurcated mesh was inserted from one end to act as a support.
  • Shrink tubing was slipped over portions of this assembly. This assembly was heated to the melting point of the polycarbonate urethane adhesive while allowing the shrink tubing to heat shrink and compress the braided mesh against the liner which is supported by the shaped mandrel. After cooling, the shrink tubing was removed and the mandrel slipped out, leaving a completed trunk component as described herein.
  • the two endoluminal tubular expandable supportive graft leg components are prepared in accordance with a similar procedure which is simpler because of the cylindrical shape of these components.
  • Example II The procedure of Example I is substantially repeated, except the liner is a double tricot polyester mesh net.
  • a trunk component of the same structure was formed, except prior to insertion of the supporting mandrel, a second, innermost liner of polycarbonate urethane is positioned in order to provide a double-lined branched component.
  • Example I and of Example II are generally followed, except here the expanded inner diameter of the trunk component is 25 mm, and the cylindrical leg endoluminal grafts are 12-15 mm in diameter.
  • a branched vascular expandable supportive endoluminal graft was made using a 16 mm diameter, 12 cm long Wallstent® device as the support component in the following manner.
  • a grounded 16 mm mandrel was rotated on a spinning machine at 500 RPM, and a spinnerette with 30 orifices was reciprocated along the axis of the mandrel at 13.8 inches/second while applying 40,000 volts to the spinnerette.
  • Polycarbonate urethane, in dimethyl acetamide solution (45% solids) was extruded from the spinnerette at 0.123 ml/min, the fibers coming onto the mandrel in random fashion to form a mat-like structure having randomly shaped pores.
  • the environment in the spinning chamber was controlled such that sufficient solvent from the urethane solution evaporated off during spinning to enable the fibers to be bond to underlying fibers during each transverse of the spinnerette.
  • the spinning procedure was stopped and the mandrel with the spun polycarbonate urethane mat was removed from the machine and cured at 110° C. for 16 hours.
  • the tubular mat still on the mandrel was trimmed to the appropriate size and the Wallstent® device was sheathed over the mesh and the ends taped down.
  • a branched aortic expandable supportive endoluminal graft is made in the following manner.
  • An aortic trunk supportive endoluminal graft is fabricated using a 16 mm diameter, 12 cm long support component.
  • a 16 mm mandrel is rotated on a spinning machine at 500 rpm, and a spinnerette with 30 orifices reciprocated along the axis of the mandrel at 13.8 inches/second.
  • Polycarbonate urethane, in dimethyl acetamide solution (45% solids) is extruded from the spinnerette at 0.123 ml/min and wound onto the rotating mandrel such that the fibers form a 50° pitch angle in relation to the axis of the mandrel.
  • the environment in the spinning chamber is controlled such that sufficient solvent from the urethane solution evaporates off during spinning to enable the fibers to bond to underlying fibers during each transverse of the spinnerette.
  • the formed spun polycarbonate urethane mesh has a length of about 16 cm, is removed from the machine and is cured at 110° C. for 16 hours.
  • the support component is sheathed over the mesh still on the mandrel.
  • Another 10 passes of polycarbonate urethane are spun over the tubular mesh, support component, but not over the 4 cm excess length of the internal tubular mesh, and the fibers, while still wet, are immediately pressed through the interstices of the support component with a silicone rubber sponge, such that the fibers bonded to the underlying fibers of the urethane mesh, thereby capturing the support component within the urethane wall.
  • the assembly is then cured for an additional 3 hours at 110° C., after which the assembly is removed from the mandrel.
  • the supportive endoluminal graft formed in this manner has fiber diameters of 10 to 20 ⁇ and pore sizes ranging from 10 to 60 ⁇ .
  • the length of the tubular mesh which is spaced about 4 cm from each side of the assembled endoprosthesis is then slit and sewn down the center such that the tube is branched into two smaller tubes along about 8 cm of the longitudinal central length of the tubular mesh.
  • the aortic trunk endoprosthesis is pulled down and sheathed on an introducer catheter, maneuvered into the aorta of a dog, via the dog's femoral artery for deployment in the abdominal aorta.
  • Two smaller stents, of 8 mm diameter, are also pulled down onto introducer catheters and maneuvered, through each femoral artery for deployment into the seam-defined two smaller tubes or “legs” of the aortic trunk.
  • the resultant branched endoprosthesis is for limiting further dilation of an abdominal-iliac aneurysm.
  • a branched expandable supportive endoluminal graft is provided for deployment within and repair of aorto-iliac aneurysms.
  • a generally tubular metallic stent of the self-expandable type is adhered to the outside of a porous spun liner as follows.
  • the graft is wound or spun from filaments deposited onto a rotating mandrel in order to form a cylindrical graft having crossing strands generally adhered together.
  • the resulting inner liner after it is dried, has a stent component placed over it. Then, an area of the stent is masked, such as with a piece of tape, at the location where an internal seam is to be positioned in the trunk component of the supportive endoluminal graft.
  • the masking can take on a shape on the order of the triangular areas illustrated in FIG. 32 , with the upper apex forming the upper “crotch” of the seam, and the lower apex forming the lower “crotch” of the seam. Additional fibers are then spun over the entire stent and pressed through the stent intersticies to be certain that the stent is secured to the liner. This continues until all areas of the stent are well-bonded except for the masked areas. After removal of the mandrel and of the masking material, the initially formed inner liner is free to be pinched along its length and sutured, sewed and/or glued and the like to form two distinct leg portions and a trunk portion of the liner. The resulting trunk component is as generally shown in FIGS. 31 and 32 .
  • the leg components of the branched supportive endoluminal graft in accordance with this Example are individually made in a similar manner.
  • the liner is formed by spinning compliant fibers over a rotating mandrel, a tubular stent component is positioned thereover and secured in place, and additional fibers are wound with the rotating mandrel.
  • the stent is thus encapsulated between the liner fibers and the cover fibers, preferably with the aid of a soft roller or sponge to force the cover strands into the interstices of the stent component and securement to the underlying liner fibers.
  • the resulting tubular supported graft component suitable for use as both the iliac components, is trimmed to proper length.
  • a branched aortic expandable supportive endoluminal graft was made using a liner of polycarbonate urethane.
  • the cylindrical liner was flattened, and a longitudinal seam was formed by heat sealing together the flattened opposing portions along a thus formed seal line.
  • a self-expanding cylindrical stent-like support component was coated on at least its inside surface with a heat-activated adhesive. The seamed liner was inserted into the stent-like support component, and the liner was inflated until the two non-seamed portions of the liner and the radially extending portions of the seamed portion of the liner engaged the inner surface of the support component.
  • this assembly with the inflated liner was placed into an oven to activate the adhesive whereby, upon subsequent cooling, the seamed liner was secured to the support component to form a branched trunk component as shown in FIGS. 31 and 32 .
  • the inflation of the liner was carried out by packing the seamed liner with salt crystals so the liner stretches in place and until adhesion between the liner and the support component had occurred.
  • a branched trunk component is prepared as described in Example VII, except the liner inflation is carried out by expanding balloon activity, and the seam is formed by suturing. Because the branched trunk component will elongate when collapsed for entry into the delivery tool, the suturing allows for longitudinal expansion and contraction back down to the as-manufactured seam length. Such suturing is achieved by using a zig-zag stitch pattern.
  • Another branched trunk component is made as described in Example VIII, except the liner inflation is carried out by a mandrel, and the sutured seam is formed with a polyurethane compliant suture material.

Abstract

An endoluminal graft which is both expandable and supportive is provided in a form suitable for use in a branched body vessel location. The graft expands between a first diameter and a second, larger diameter. The support component is an expandable stent endoprosthesis. A liner is applied to the endoprosthesis in the form of a compliant wall material that is porous and biocompatible in order to allow normal cellular invasion upon implantation, without stenosis, when the expandable and supportive graft is at its second diameter. The supportive endoluminal graft is preferably provided as a plurality of components that are deployed separately at the branching body vessel location, one of which has a longitudinal seam defining leg portions within which the other components fit in a telescoping manner.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This is a divisional application of application Ser. No. 09/657,041, filed Sep. 5, 2000, which is a reissue application of U.S. Pat. No. 5,855,598 issued Jan. 5, 1999, which is a continuation-in-part of application Ser. No. 08/558,028, filed Nov. 13, 1995, filed Nov. 13, 1995, now U.S. Pat. No. 5,632,772 and application Ser. No. 08/558,034, filed Nov. 13, 1995, now U.S. Pat. No. 5,639,278, which are each a continuation-in-part of application Ser. No. 140,245, filed Oct. 21, 1993, now abandoned and is related to divisional reissue application Ser. No. 10/788,966, filed Feb. 25, 2004, and continuation reissue application Ser. No. 11/332,917, filed Jan. 17, 2006.
  • BACKGROUND AND DESCRIPTION OF THE INVENTION
  • This invention generally relates to supportive endoluminal grafts which have the ability to be delivered transluminally and expanded in place to provide a graft that is endoluminally positioned and placed, with the aid of an appropriate inserter or catheter, and that remains so placed in order to both repair a vessel defect and provide lasting support at the location of the graft. In its broadest sense, the graft preferably combines into a single structure both an expandable luminal prosthesis tubular support component and a compliant graft component secured thereto. The expandable supportive endoluminal graft takes on a bifurcated or branched structure made up of components that are designed to be positioned in a bifurcated manner with respect to each other, preferably during deployment or repair and support of vessel locations at or near branching sites. Preferably, the graft component is compliant, stretchable or elastomeric and does not substantially inhibit expansion of the tubular support component while simultaneously exhibiting porosity which facilitates normal cellular growth or invasion thereinto of tissue from the body passageway after implantation.
  • Elastomeric vascular grafts are known to be made by various methods. Included are methods which incorporate electrostatic spinning technology such as that described by Annis et al. in “An Elastomeric Vascular Prosthesis”, Trans. Am. Soc. Artif. Intern. Organs, Vol. XXIV, pages 209-214 (1978) and in U.S. Pat. No. 4,323,525. Other approaches include elution of particulate material from tubular sheeting, such as by incorporating salts, sugars, proteins, water-soluble hydrogels, such as polyvinyl pyrrolidone, polyvinyl alcohol, and the like, within polymers and then eluting the particulate materials by immersion in water or other solvent, thereby forming pores within the polymer. Exemplary in this regard is U.S. Pat. No. 4,459,252, incorporated by reference hereinto. Another approach involves the forming of pores in polymers by phase inversion techniques wherein a solventized polymer is immersed in another solvent and the polymer coagulates while the polymer solvent is removed. Also known are spinning techniques such as those described in U.S. Pat. No. 4,475,972. By that approach, a polymer such as a polyurethane in solution is extruded as fibers from a spinnerette onto a rotating mandrel. The spinnerette system reciprocates along a path which is generally parallel to the longitudinal axis of the mandrel and at a controlled pitch angle. The result is a non-woven structure where each fiber layer is bound to the underlying fiber layer.
  • Also known are stent devices, which are placed or implanted within a blood vessel or other body cavity or vessel for treating occlusions, stenoses, aneurysms, disease, damage or the like within the vessel. These stents are implanted within the vascular system or other system or body vessel to reinforce collapsing, partially occluded, weakened, diseased, damaged or abnormally dilated sections of the vessel. At times, stents are used to treat disease at or near a branch, bifurcation and/or anastomosis. This runs the risk of compromising the degree of patency of the primary vessel and/or its branches or bifurcation, which may occur as a result of several problems such as displacing diseased tissue, vessel spasm, dissection with or without intimal flaps, thrombosis and embolism.
  • One common procedure for implanting a stent is to first open the region of the vessel with a balloon catheter and then place the stent in a position that bridges the diseased portion of the vessel. Various constructions and designs of stents are known. U.S. Pat. No. 4,140,126 describes a technique for positioning an elongated cylindrical stent at a region of an aneurysm to avoid catastrophic failure of the blood vessel wall, the stent being a cylinder that expands to an implanted configuration after insertion with the aid of a catheter. Other such devices are illustrated in U.S. Pat. Nos. 4,787,899 and 5,104,399. U.S. Pat. Nos. 4,503,569 and 4,512,338 show spring stents which expand to an implanted configuration with a change in temperature. It is implanted in a coiled configuration and then heated in place to cause the material of the spring to expand. Spring-into-place stents are shown in U.S. Pat. No. 4,580,568. U.S. Pat. No. 4,733,665 shows a number of stent configurations for implantation with the aid of a balloon catheter. U.S. Pat. No. 5,019,090 shows a generally cylindrical stent formed from a wire that is bent into a series of tight turns and then spirally wound about a cylindrical mandrel to form the stent. When radially outwardly directed forces are applied to the stent, such as by the balloon of an angioplasty catheter, the sharp bends open up and the stent diameter enlarges. U.S. Pat. No. 4,994,071 describes a bifurcating stent having a plurality of wire loops that are interconnected by an elongated wire backbone and/or by wire connections and half hitches.
  • Stents themselves often do not encourage normal cellular invasion and can lead to undisciplined development of cells in the stent mesh, with rapid development of cellular hyperplasia. Grafts alone do not provide adequate support in certain instances. Copending application of Jean-Pierre Dereume, Ser. No. 08/546,524, entitled “Luminal Graft Endoprostheses and Manufacture Thereof” describes grafts that have the ability to carry out dilatation and/or support functions. An expandable tubular support component and an elastomeric graft component are combined into a single device wherein the graft material is secured to either or both of the internal and external surfaces of the expandable support component. The graft material is produced by a spinning technique such as that described in U.S. Pat. No. 4,475,972. Also, luminal endoprostheses with an expandable coating on the surface of external walls of radially expandable tubular supports are proposed in U.S. Pat. Nos. 4,739,762 and 4,776,337. In these two patents, the coating is made from thin elastic polyurethane, Teflon film or a film of an inert biocompatible material. A. Balko et al., “Transfemoral Placement of Intraluminal Polyurethane Prosthesis for Abdominal Aortic Aneurysm”, Journal of Surgical Research, 40, 305-309, 1986, and U.S. Pat. Nos. 5,019,090 and 5,092,877 mention the possibility to coat stent materials with porous or textured surfaces for cellular ingrowth or with non-thrombogenic agents and/or drugs. The various patents and publications referred to hereinabove are incorporated hereinto by reference.
  • By the present invention, grafts which are expandable and supportive are provided that expand from a first diameter to a second diameter which is greater than the first. When it is at its first diameter, the expandable supportive graft is of a size and shape suitable for insertion into the desired body passageway. The material of the graft is substantially inert and preferably has a generally cylindrical cover and/or lining generally over the outside and/or inside surface of the expandable supportive component. Preferably, the cover and/or lining is especially advantageous because it is compliant or elastomeric and porous to encourage desirable growth of tissue thereinto in order to assist in non-rejecting securement into place and avoidance of stenosis development. The porous liner and/or cover material is compliant or elastomeric enough to allow for expansion by up to about 2 to 4 times or more of its unexpanded diameter. Components of the branched or bifurcated expandable supportive endoluminal graft preferably are deployable separately such that each component is properly positioned with respect to the other into the desired branched or bifurcated arrangement. One of the components has a portion which has at least one longitudinally disposed indent to generally define at least two leg portions for receiving one of the other components.
  • It is a general object of the present invention to provide an improved branched endoluminal graft that is expandable in place and, once expanded, is self-supporting.
  • Another object of this invention is to provide biocompatible grafts having a plurality of components that are separately expandable in vivo and that are supportive once so expanded.
  • Another object of the present invention is to provide an improved expandable reinforced graft that is delivered by way of introducers, balloon catheters or similar devices, and which facilitates good tissue ingrowth.
  • Another object of this invention is to provide an improved endoluminal graft which fully covers diseased or damaged areas for carrying out luminal repairs or treatments, such as repair of aneurysms.
  • Another object of the present invention is to provide an improved endoluminal graft wherein the endoprosthesis is substantially enclosed within biocompatible compliant material which is presented to the surrounding tissue and blood or other body fluid.
  • Another object of this invention is to provide an expandable, supportive graft that can be tailored to meet a variety of needs, including a single graft designed to address more than a single objective.
  • Another object of the present invention is to provide a self-expanding reinforced graft device that is delivered in its elongated and compressed state from within a tubular member and deployed by moving same out of the tubular member, which device is especially suitable for component deployment.
  • Another object of this invention is to provide a bifurcated trunk component that is deployed in a collapsed state and expanded in vivo to a branched device for use in treatment and/or repair at branched vessel locations.
  • A further object of the present invention is to provide a component branched endoluminal graft having a longitudinally creased trunk component and at least one cylindrical branch component, which components are expanded separately after endoluminal delivery and which form a bifurcated graft once positioned with respect to each other and expanded.
  • Another object of this invention is to provide an improved method of forming a branched endoluminal graft incorporating a longitudinal creasing procedure.
  • Another object of the present invention is to provide an improved method of assembling a branched endoluminal graft.
  • These and other objects, features and advantages of this invention will be clearly understood through a consideration of the following detailed description.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be further elucidated in the following description with reference to the drawings, in which:
  • FIG. 1 is a perspective view, partially cut away, of an expandable supportive endoluminal graft construction in accordance with the invention;
  • FIG. 2 is a cross-sectional view along the line 2-2 of FIG. 1;
  • FIG. 3 is a perspective view, partially cut away, of another embodiment of the expandable supportive endoluminal graft construction;
  • FIG. 4 is a cross-sectional view along the line 4-4 of FIG. 3;
  • FIG. 5 is a perspective view, partially cut away, of a further embodiment of the expandable luminal graft construction;
  • FIG. 6 is a cross-sectional view along the line 6-6 of FIG. 5;
  • FIG. 7 is a perspective view, partially cut away, of a bifurcated expandable supportive endoluminal graft construction;
  • FIG. 8 is a cross-sectional view along the line 8-8 of FIG. 7;
  • FIG. 9 is a somewhat schematic view illustrating an early step in the implantation of a device such as shown in FIG. 7;
  • FIGS. 10, 11 and 12 are generally schematic views along the lines of FIG. 9 showing expansion of the main body and the branches of this bifurcated device;
  • FIG. 13 shows this bifurcated supportive graft after completion of the expansion procedure;
  • FIG. 14 illustrates another embodiment of a bifurcated expandable supportive endoluminal graft construction;
  • FIGS. 15, 16 and 17 illustrate implantation and assembly of the graft of FIG. 14;
  • FIGS. 18, 19, 20 and 21 illustrate a component branched graft and various stages of its separate, component deployment within a body vessel to repair an aneurysm, FIGS. 18 and 19 showing deployment of a preferred branched, longitudinally indented trunk component, and
  • FIGS. 20 and 21 showing separate deployment of two branch components within the trunk component;
  • FIG. 22 is a top plan view of an embodiment of a branching trunk component in accordance with the invention;
  • FIG. 23 is a cross-sectional view along the line 23-23 of FIG. 22;
  • FIG. 24 is a side elevational view of the branching trunk component as illustrated in FIGS. 22 and 23;
  • FIG. 25 is an end view of the structure as shown in FIG. 24;
  • FIG. 26 is a perspective, generally exploded view of an example of a fixture suitable for forming the longitudinal crease in this trunk component;
  • FIG. 27 is a longitudinal broken-away view of the fixture of FIG. 26 with a braided cylindrical tube positioned therein;
  • FIG. 28 is a view generally in accordance with FIG. 27, showing formation of opposing crease indents in the braided cylindrical tube during formation of this trunk component;
  • FIG. 29 is a top plan view showing assembly of supportive endoprosthesis leg components into a branching trunk component according to the invention;
  • FIG. 30 is an end view of the structure as shown in FIG. 29;
  • FIG. 31 is a perspective view of another embodiment of a branching trunk component in accordance with the invention;
  • FIG. 32 is a cross-sectional view along the line 32-32 of FIG. 31; and
  • FIG. 33 is a perspective view of a modified embodiment of a branching trunk component, having a section of enhanced hoop strength.
  • DESCRIPTION OF THE PARTICULAR EMBODIMENTS
  • An embodiment of expandable supportive luminal graft construction is generally illustrated in FIG. 1 at 21. This embodiment includes a braided tubular support component having generally helically wound rigid but flexible strand or wire elements, some of which have the same direction of winding but are axially displaced from one another, and others of which cross these windings and are also axially displaced with respect to each other. The actual structure can be generally braided as illustrated in Wallsten U.S. Pat. No. 4,655,771, incorporated by reference hereinto, or as found in self-expanding braided flat wire Wallstent® devices. Both a cover 23 and a liner 24 are illustrated in FIGS. 1 and 2. Either cover 23 or liner 24 can be omitted if there is no desire to substantially encapsulate the tubular support component 22.
  • With more particular reference to the illustrated cover 23 and liner 24, when included, they may be formed by an electrostatic spinning process in this illustrative embodiment. Details regarding electrostatic spinning techniques in general are found in Bornat U.S. Pat. No. 4,323,525 and in Bornat European patent publication No. 9,941, as well as in the Annis et al. article discussed hereinabove, the disclosures of which are incorporated by reference hereinto. With further reference to the application of this technology to the expandable supportable luminal grafts of the present invention, random pattern filaments are formed and electrostatically directed toward a charged mandrel in order to form a random pattern of electrostatically generally cross-linked filaments which take on the configuration of a mat having a cylindrical shape. The filament diameters are particularly fine, as is the pore size of the mat so constructed. A typical range of filament diameters is between about 0.5 micron and about 5 microns, and a typical pore size of the electrostatically spun fiber is between about 3 microns and about 20 microns.
  • Liner 24 is formed directly on the rotating mandrel by this electrostatic spinning procedure. Thereafter, one of the tubular support components discussed herein, such as the generally braided tubular support 22, is placed over the liner 24 still on the mandrel. In the case of the tubular support 22 in a form that is not spring loaded, this includes longitudinally extending the tubular support 22, such as by pulling one or both of its ends, which thereby decreases its diameter so that it fits snugly over the liner 24. When the generally braided tubular support 22 is of a spring-into-place type, a hold-down member (such as shown in FIGS. 18 and 20) is used to prevent automatic radial expansion prior to deployment. When the expandable supportive graft 21 is to include a cover 23, the mandrel is again rotated, and the electrostatic spinning is again accomplished in order to form the cover 23 directly over the tubular support 22. This will also create some bonding between the thus formed cover 23 and the liner 24 at openings between the strands or wires of the woven tubular support 22 or the like. This bonding can be facilitated by uniformly compressing the outer fibers with a soft silicone roller or sponge such that the still tacky outer fibers bond to the inner fibers thereby encapsulating the tubular support within the graft.
  • Bonding may also be achieved in this or other embodiments by heat welding and/or by the use of adhesives such as hot melt adhesives, primers, coupling agents, silicone adhesives, and the like, and combinations of these. Examples include aliphatic polycarbonate urethane hot melts and silicone rubber adhesives.
  • It is important to note that each of the cover 23 and the liner 24, when either or both are present, is made of an elastomeric material which retains its compliant properties after construction of the expandable supportive graft 21 is completed. In this regard, the graft itself is also elastomeric and compliant. Accordingly, the graft 21 is delivered transluminally, such as by being pulled down onto the balloon of a catheter or into an inserter tube and then percutaneously inserted and positioned to the location where the repair is needed. For a non-spring loaded graft, the balloon is then inflated to longitudinally shorten and radially expand the graft 21 into engagement with the vessel walls. Because of the compliance of the cover 23 and/or liner 24, and because of the hoop strength of the braided tubular support 22, the graft 21 will remain in place. In the illustrated embodiment, ends 25 of the tubular support are exposed and are not covered by the cover 23. This allows the exposed end portions 25 to directly engage the vessel wall, if desired in the particular application, in order to assist in anchoring the graft 21 in place. Liner 24 also can be sized so as to not cover the exposed ends 25, or it can extend to or beyond the edge of the ends 25 when it is desired to avoid or minimize contact between the tubular support and the blood or other fluid flowing through the vessel being repaired or treated.
  • Alternatively, when a braided tubular support such as that illustrated in FIGS. 1 and 2 is incorporated into the graft according to the present invention in a non-spring-loaded form, transluminal delivery can be made by way of a catheter or tool having means for longitudinally compressing the endoprosthesis until it has expanded radially to the desired implanted diameter. Such equipment typically includes a member that engages one end of the endoprosthesis and another member which engages the other end of the endoprosthesis. Manipulation of proximally located controls then effects relative movement of the members toward each other in order to thereby longitudinally compress the endoprosthesis. Delivery tools for spring-loaded grafts include a sleeve that maintains the graft at its compressed diameter until the graft is positioned for deployment such as from the end of an insertion catheter to its auto-expanded state.
  • With reference to the embodiment illustrated in FIGS. 3 and 4, an expandable supportive graft is illustrated at 31. The illustrated tubular support component 32 is constructed of sinusoidally configured wire helically wound into a tubular shape. General structures of these types are generally discussed in Pinchuk U.S. Pat. No. 5,019,090, incorporated by reference hereinto. A cover 33 can be positioned over the tubular support 32 and/or a liner 34 can be positioned along its lumen. In this illustrated embodiment, the cover 33 and liner 34 are constructed of porous polymers, the pores thereof having been made by elution or extraction of salts and the like, such as described in MacGregor U.S. Pat. No. 4,459,252, incorporated by reference hereinto. Generally speaking, the porosity is determined by the size of the elutable particles as discussed herein and by the concentration of those particles as a percent by volume of a pre-elution mixture thereof with the polymer of the cover or liner. When a graft 31 having both a cover 33 and a liner 34 is prepared, a mandrel or rod is dipped into a liquid polymer having elutable particles as discussed herein dispersed therewithin. After dipping, the polymer covered rod is contacted with, such as by dipping or spraying, a solvent, for the elutable particles, such as water, thereby forming the eluted porous liner 34. Thereafter, the tubular support 32 is positioned thereover and pressed down into the liner. Then, the rod and the assembly thereon are again dipped into the mixture of polymer and elutable particles, followed by setting and contact with solvent to remove the elutable particles in order to form the eluted porous cover 33. It is also possible to directly extrude the particle-containing polymer into a tubular shape.
  • Elutable particles which can be used in the making of the eluted porous cover 33 and liner 34 include salts such as sodium chloride crystals, sodium carbonate, calcium fluoride, magnesium sulfate and other water-soluble materials that are readily dissolved by the utilization of water as an elution medium. Other particles that are soluble in organic solvents and the like can be substituted as desired. Further particles include sugars, proteins, and water-soluble hydrogels such as polyvinyl pyrrolidone and polyvinyl alcohol. Suitable polymer materials are as discussed elsewhere herein, the pore size being on the order of about 10 microns to about 80 microns.
  • As with the other embodiments, when desired, ends 35 of the support component 32 can be exposed either on one or both of its cylindrical faces in accordance with the needs of the particular repair or treatment to be carried out. With this approach, the exposed ends 35 will assist in maintaining the graft 32 in place by mechanical engagement between the exposed ends 35 and the vessel being repaired or treated and/or by tissue ingrowth. The anchoring aspect of the exposed ends of the tubular support can be enhanced by continued radial expansion of the balloon or other deployment means which will permit the exposed ends to expand radially outwardly in an amount somewhat greater than that of the rest of the expandable supportive graft and into the surrounding tissue. It is also contemplated that mechanical means can be used to assist in joining the exposed ends of this embodiment or of other embodiments to the vessel wall. An illustrative example in this regard is the use of transluminally delivered staples which can take on the appearance of rivets. Especially advantageous are staples made of an elastomeric material. Illustrated staples are shown at 36 in FIG. 3. They can be incorporated at other locations as well along the graft. One or more windows 37 can be formed through the cover and/or liner and/or tubular support in order to feed outside branch arteries or other vessels.
  • FIGS. 5 and 6 illustrate a further embodiment of an expandable supported graft, generally designated as 41. Shown is a mesh tubular support component, generally designated as 42, such as those of the type illustrated in Palmaz U.S. Pat. No. 4,733,665, incorporated by reference hereinto. These are non-woven mesh-type cylinders or slotted tubes wherein most or all of the individual components are either integrally joined together such as by welding or are integrally formed from a single tube. The resulting endoprostheses are malleable enough so as to be expandable by a balloon of a catheter. Usually, these endoprostheses have particularly high hoop strengths.
  • Cover 43 and/or liner 44 are made of polymers rendered porous by phase inversion techniques. In accordance with these techniques, a polymer such as a polyurethane is dissolved in a solvent therefor, for example a water-soluble polar solvent, such as dimethyl acetamide, tetrahydrofuran and the like, in order to form what is known as a lacquer. A mandrel or rod is dipped into the lacquer. Thereafter, the dipped rod is contacted with an inversion solvent, such as by dipping in water or a mixture of alcohol and water. This inversion solvent must readily dissolve the polymer solvent of the lacquer, while at the same time being a poor solvent for the polymer. Under these conditions, the polymer coagulates and the polymer solvent of the lacquer is removed and replaced with the inversion solvent. The inversion solvent pulls the polymer solvent out of the polymer on the rod and forms particularly fine pores having a pore size on the order of about 0.5 micron to about 20 microns. The thus formed liner 44 having phase inversion pores is then dried.
  • Next, the tubular support component 42 is secured over the liner 44 and is preferably radially compressed onto and into the liner. Thereafter, the cover 43 having phase inversion pores is formed in accordance with the same phase inversion steps as discussed hereinabove for preparation of the liner 44. If desired, either the liner or the cover can be omitted. Cover 43 and liner 44 are thus formed in accordance with a displacing step wherein precipitating non-solvent molecules are substituted for non-precipitating solvent molecules dispersed throughout the lacquer coating. This procedure develops advantageous elastic characteristics. Further details regarding the phase inversion procedure are found in Lymann et al. U.S. Pat. No. 4,173,689, incorporated by reference hereinto.
  • FIGS. 7 and 8 illustrate an embodiment wherein the graft takes the form of a bifurcated expandable supportive graft, generally designated at 51. Included is a joined-ring bifurcated tubular support 52. Also shown are a bifurcated cover 53, a bifurcated lining 54 and exposed ends 55, 56, 57. This particular bifurcating graft is well-suited for insertion into a branching vessel.
  • The tubular support includes a plurality of rings or loops 58 connected by flexible interconnections 59. Constructional details of embodiments of the rings or loops 58 and of the flexible interconnections 59 are found in MacGregor U.S. Pat. No. 4,994,071, incorporated by reference hereinto. The flexible interconnections 59 join the rings or loops 58 into a configuration having a main body or trunk 61 and one or more branches 62. Flexible interconnections 59 extend longitudinally from the axis of each of the main body or trunk 61 and branch 62, 63. At least one such flexible interconnection joins each branch to the trunk. The loops 58 in the main body are substantially parallel to each other, and the loops 58 in each branch 62, 63 are substantially parallel to each other.
  • The bifurcated cover 53 and bifurcated liner 54 must each, when provided, be especially elastomeric so as to follow the expansion and contraction of the rings or loops 58 that takes place during preparation, transluminal insertion, deployment and the like. Cover 53 and liner 54 will also take on a bifurcated construction. In one embodiment, the liner and/or cover for each of the trunk 61 and branch 62, 63 are made on a cylindrical mandrel, assembled and joined, such as by suitable biocompatible adhesive, fusion, sewing, suturing or other means of joining and/or sealing. Alternatively, a Y-shaped or branched mandrel can be used. The bifurcating liner is then formed thereon by processes such as those discussed herein, including electrostatic spinning, or dipping followed by elution or phase inversion procedures much in the same manner as described herein when straight cylindrical mandrels or rods are used for constructing the non-bifurcated grafts in accordance with this invention. Fiber winding can also be practiced. Bifurcated cover 53 is made in a similar manner by application of the porous cover material over the bifurcated endoprosthesis.
  • With reference to the bifurcated endoprosthesis, the bifurcated cover 53 and/or bifurcated liner 54 could be made by fiber winding approaches, such as those described in Wong U.S. Pat. No. 4,475,972, the subject matter thereof being incorporated by reference hereinto. Polymer in solution is extruded into fibers from a spinnerette onto a rotating mandrel. The spinnerette is reciprocated along the longitudinal axis of the mandrel at a controlled pitch angle, resulting in a non-woven cylinder wherein each fiber layer is bound to the underlying layer. Control of the pitch angle allows for control of the compliance and kink resistance of the cover and/or liner. In an especially advantageous arrangement when using these fiber spinning techniques in forming an expandable supportive graft in accordance with the general aspects of this invention which has both a liner and a cover, the cover is physically bonded to the liner by the use of an electrostatic field to enable penetration of the cover overlay of fibers through the interstices of the support components in order to improve the bonding of the cover and/or liner fibers to each other and/or to surfaces of the support component.
  • With more particular reference to balloon deployment of expandable supportive grafts, this is illustrated with some particularity in connection with bifurcated endoluminal grafts in FIGS. 9, 10, 11, 12 and 13. As shown in FIG. 9, two guidewires 64, 65 are inserted into the bifurcating vessel, each of them into different legs 66, 67 of the bifurcating vessel. Thereafter, the unexpanded bifurcated expandable supportive graft 51 is slipped over the proximal ends of the guidewires and routed to the branches of the blood vessel. The unexpanded bifurcated graft can be introduced from an arteriotomy proximal to the bifurcation such as from the brachial artery in the arm, or the unexpanded bifurcated graft can be introduced from the femoral artery in the leg, pushed proximally past the bifurcation and then pulled back distally into both iliacs to form the trunk and bifurcation.
  • The two branches 62, 63 of the graft 51 are routed separately over the guidewires 64, 65, respectively, and guided, typically with the help of a guide catheter, into the patient until the graft is positioned as shown in FIG. 9. The graft 51 is initially fixed in place as follows. One of the guidewires 65 is removed, and a balloon catheter 68 is inserted into the main body or trunk 61 and inflated to expand the trunk 61 into contact with the vessel walls. This deployment is suitable to secure the graft 51 in place at that location of the vessel.
  • The balloon of balloon catheter 68 is then deflated. If this balloon catheter is also suitable for use in expanding the branches 62, 63 of the graft 51, same is then inserted into an unexpanded branch 62 and radially expanded as generally shown in FIG. 11. If the balloon of catheter 68 is not suitable in this regard, then another balloon catheter 69 effects this function. FIG. 12 shows inflation of the other branch 63 of the graft 51 in a similar manner. FIG. 13 illustrates the fully deployed and expanded bifurcated support graft 51 positioned in place within the bifurcated location. Alternatively, a bifurcated dilation balloon on a bifurcated catheter (not shown) can replace the single-balloon catheter(s) 68, 69.
  • Preferably the branched and assembled expandable supportive graft is of the spring-into-place type; as such, it will be manipulated to be reduced in diameter and placed within an overlying and bifurcated restraining guiding catheter or the like and will be passed over guidewires and contained within the guiding catheter until proper placement within the bifurcating location. This type of bifurcated expandable supportive graft is deployed by being ejected into place, typically by advancing a small inner catheter through the guiding catheter into contact with the bifurcating graft in accordance with the procedure generally used for spring-into-place stents.
  • The deployment procedures illustrated in FIGS. 9 through 13 can be characterized as prograde deployment. Retrograde deployment is also possible. The entire bifurcating graft for retrograde deployment is advanced over a single guidewire through one branch of the blood vessel past the point of bifurcation. A second guidewire is then steered down the opposite limb of the graft, and a snare is used. The snare, which is passed retrograde through the opposite vessel, is then used to pull the guidewire into place. Partial balloon inflation in the unbranched or trunk portion of the blood vessel is then used to draw the graft down into position prior to balloon dilatation of both the trunk and branched portions of the graft. Because blood flow is prograde under these circumstances, the contact between the bifurcation of the graft and the bifurcation of the blood vessel helps to prevent the graft from migrating distally, thus reducing the need for active fixation of the graft to the blood vessel.
  • Another bifurcated endoprosthesis or expandable supportive graft is generally designated 81 in FIG. 14. Separate components are included. In this case tubular supporting component(s) are, prior to deployment, separate from a trunk component. In this embodiment, a fully independent tubular supporting component 82 is located at the trunk position of the graft 81. A bifurcated stretchable wall 83 is in contact with the independent tubular supporting component 82 as either or both of a cover or liner. In addition to being substantially coextensive with the independent tubular supporting component 82 at a trunk portion 84 thereof, the stretchable wall 83 includes at least two generally tubular stretchable branch sleeves 85, 86 which are initially devoid of a supporting component. Separate tubular supporting components 87, 88 (FIGS. 16 and 17) are also included.
  • Implantation of this bifurcated expandable supportive graft is depicted in FIGS. 14, 15, 16 and 17. Dual guidewires 64, 65 can be used to properly position the unexpanded bifurcated graft 81 within the bifurcating vessel as shown in FIG. 14. A balloon catheter 68 or similarly functioning device is inserted into the main body of the device so as to expand the independent tubular supporting component 82 and the trunk portion 84 of the bifurcated stretchable wall 83. This deployment initially secures the bifurcated supporting graft into place at that location of the vessel, as shown in FIG. 15. The balloon catheter is then deflated and removed or positioned for use in the next step.
  • A suitable balloon catheter 69 or the like is next used to deploy and expand in place a branch tubular expandable supporting component 89, as illustrated in FIG. 16. A similar step deploys and expands in place another branch tubular expandable supporting component 90, as generally shown in FIG. 17. The bifurcated stretchable wall 83 and the expandable supporting components may be made with the materials and constructions discussed herein and may be subjected to various treatments as discussed.
  • A further bifurcated endoprosthesis or expandable supportive graft is one in which the separate components are each expandable supportive graft members. These separate components are illustrated in FIG. 18 through FIG. 21, which also illustrate their separate deployment with respect to each other within an aortic trunk. Same is shown in connection with treating an aneurysm such as an abdominal aorto-iliac aneurysm. The device includes a trunk component 101 which, in the illustrated use, is designed to extend from below the renal arteries to a location between the proximal neck of the aneurysm and the aorto-iliac bifurcation. It will be understood that this trunk component could also be shorter so that it terminates just below the proximal neck of the aneurysm, for example of a length which terminates within the dent or crease 124. In addition, the component bifurcated expandable supportive graft of this embodiment is self-expanding and is deployed by means of an introducer containing compressed expandable supportive graft components.
  • More particularly, and with reference firstly to FIG. 18, a guidewire 102 is first inserted in accordance with known procedures so as to traverse the aneurysm 103. Next, an introducer, generally designed as 104 having the trunk component therewithin in a radially compressed state is inserted over the guidewire 102. The introducer is maneuvered such that it is properly positioned as desired, in this case at a location distal of the distal end of the aneurysm. Then, the sheath 105 of the introducer is withdrawn, such as by sliding it in a proximal direction while the remainder of the introducer 104 remains in place. As the sheath is withdrawn, the trunk 101 expands, eventually achieving the deployed or implanted position shown in FIG. 19. At this stage, the distal portion 106 of the trunk is well anchored into the blood vessel wall and is suitably deployed.
  • FIG. 20 shows an introducer, generally designated as 107, having an independent tubular expandable supportive graft leg component 108 (FIG. 21) radially compressed therewithin. In this illustrated embodiment, this leg component is an iliac component of the bifurcated supportive graft being assembled within the body vessel. The introducer 107 is advanced until this iliac component is moved into a leg 109 of the already deployed trunk component 101. This positioning is illustrated in FIG. 21. It will be noted that the iliac tubular supportive graft component 108 extends from well within the leg 109 to a location proximal of the aneurysm in the iliac artery 110.
  • In a previous step, a guidewire had been passed through the appropriate vessel to iliac artery 112 until it crossed the aneurysm 103, while passing through the other leg 113 of the deployed trunk component 101. When the introducer for the previously radially compressed iliac component 115 had been removed, the component 115 had expanded radially and was deployed. Thus, the entirety of the bifurcated endoprosthesis or expandable supportive graft in accordance with this embodiment is fully deployed and assembled together as shown in FIG. 21, as well as generally depicted in FIGS. 29 and 30.
  • It will be noted that it is not required to actually attach the trunk component 101 and the tubular components 108, 115 together. In other words, these components are generally telescopically positioned with respect to each other. This telescopic feature allows some slippage between the trunk component and the tubular leg components, thereby providing a telescopic joint which functions as a slip bearing. It will be appreciated that it is generally desirable to firmly anchor portions of the bifurcated endoprosthesis within healthy vessel wall tissue. This can be achieved by the hoop strength of the supportive graft or by taking measures to enhance hoop strength at its ends, or by providing grasping structures such as hooks, barbs, flared ends and the like. During pulsetile blood flow and possibly during exercise by the person within which the endoprosthesis is implanted, tension and elongation forces are imparted to the endoprosthesis. In structures that do not have a telescopic joint or some other means to relieve the stress developed by this tension, a considerable amount of stress can be placed on the anchoring sites and/or the attachment components, potentially allowing for dislodgement at the anchoring sites or breakage of attachment components.
  • FIGS. 22, 23, 24 and 25 further illustrate a trunk component 101. It includes a common trunk portion 118 and a branched portion, generally designated as 119. The branched portion includes the legs 109 and 113. In this embodiment, a further common trunk portion 120 is located opposite the other common trunk portion 118 and extending from the branched portion 119. Thus, the overall configuration of the trunk component is that of a double-lumen length located between two single-lumen lengths. The common trunk portion 118 can be positioned, for example, in the aortic artery, the branched portion 119 provides a bifurcation structure to direct blood flow into the two iliac arteries, and the further common trunk portion 120 facilitates deployment of the leg components into the branched portion 119, acting in the nature of a funnel for each guidewire, introducer and contracted leg component.
  • Trunk component 101 includes a stent or tubular supporting component 121. Also included is a liner, generally designated as 122. A further liner 123 preferably is located interiorly of the liner 122. Liners 122, 123 are secured within the stent component 121 in order to provide proper porosity for an endoprosthesis.
  • Trunk component 101 includes one or more indents, such as indent 124 and indent 125. A third, a fourth, or further indents can be provided depending upon the degree of branching desired. It will be appreciated that one or more tubular expandable supportive leg graft components will be provided in order to slide into the branched passageways which are thus defined by the indent(s). In the illustrated embodiment, one such leg component 108 slidingly engages an opening 126 of the trunk component leg 109, while a second leg component 115 slidingly and expansively fits within opening 127 of the leg component 115.
  • With particular reference to FIGS. 31-33, this shows a trunk component 101 c which has a function and a configuration along the lines of trunk component 101, except only the liner defines the indent or indents. In this arrangement, the tubular supporting component is cylindrical in cross-section substantially throughout its length.
  • FIG. 31 illustrates the trunk component 101 c. It includes a common trunk portion 118 c and a branched portion, generally designated as 119 c. The bifurcated or branched portion includes the legs 109 c and 113 c. In this embodiment, a further common trunk portion 120 c is located opposite the other common trunk portion 118 c and extends from the branched or bifurcated portion 119 c. Thus, as with trunk component 101, the overall configuration of trunk component 101 c is that of a double-lumen length located between two single-lumen lengths.
  • Trunk component 101 c includes a stent or tubular supporting component 121 c, as perhaps best seen in FIG. 32. Also included is a liner, generally designated as 122 c. This liner 122 c has a body portion 123 c and the legs 109 c and 113 c which open into another body portion 151.
  • Each leg 109 c, 113 c is secured to the generally tubular stent component 121 c at outside portions thereof, particularly at adhesion zones 124 c and 125 c. The remainder of the leg portions 109 c and 113 c are not so bonded to the stent portion 121 c. This facilitates formation of the leg portions, which are typically pinched along the length of the legs in order to form at least one internal seam 126 c. Leg openings 127 c and 128 c are thereby generally defined between this seam 126 c and the adhesion zones 124 c and 125 c.
  • In FIG. 33, means are included in the trunk component 101 d which provides enhanced securement upon implantation. A stent component 129 d is included which has a substantially higher pitch angle (for example, between about 140° and 180°) than does the stent portion 121 d therebelow within which the legs are positioned (for example, at a pitch angle of between about 70° and 90°). This higher pitch angle zone imparts a greater hoop strength upon deployment than does the stent 121 c of the trunk component 101 c. A barb 130 is also shown in order to further assist in securement of the endoprosthesis to the artery wall. When desired, the barb-type of structure can be a backing ring and barb formed out of the stent strand during its formation into the cylindrical supportive member.
  • Any of the various expandable supportive endoluminal graft, or stent graft, constructions discussed or referred to herein can be used in order to construct devices in accordance with this embodiment. Other modifications may also be incorporated, including tubes having stepped diameters or conical ends. The stent component can be made with flat wires or with pairs of wires or multifilament wires. They can incorporate balloon expandable stents, self-expanding stents, and combinations of balloon expandable stents and self-expanding stents. Use can be made of ancillary equipment such as endoluminal stapling devices or suturing devices in order to facilitate securement at the aneurysm neck, for example. Also, a portion of the stent component without a liner component or the like thereon can project at the proximal end of the endoluminal component, such as at a location which would be above the renal arteries. The objective is also to help to secure the device in place.
  • The prosthesis as discussed is deployed to replace or repair tubular bodies such as blood vessels, tracheas, ureters and the like, accommodating more than one conduit in order to divert flow to other branches of the tubular body. This allows for repair of a bifurcated area which is difficult to repair using a single-lumen device or a plurality of individual single-lumen devices. It is suitable for repair of damages to branched conduits or, conversely, to repair conduits which converge into a single branch.
  • A preferred use for the bifurcating endoluminal grafts discussed herein is for insertion into a branching blood vessel. Same is typically suitable for use in the coronary vasculature (the right, left common, left anterior descending, and circumflex coronary arteries and their branches) and the peripheral vasculature (branches of the carotid, aorta, femoral, popliteal arteries and the like). These bifurcated devices are also suitable for implantation into other branching vessels such as in the gastrointestinal system, the tracheobronchial tree, the biliary system, and the genitourinary system.
  • It will be appreciated that the expandable supportive grafts in accordance with the present invention will dilate and/or support blood vessel lesions and other defects or diseased areas, including at or in proximity to sites of vascular bifurcations, branches and/or anastomoses. The expandable supportive graft is an integral structure that incorporates the expandable support component into the wall or walls of the elastomeric graft. Covers and/or linings that make up the grafts interface with body components that facilitate normal cellular invasion without stenosis or recurrent stenosis when the graft is in its expanded, supportive orientation. The graft material is inert and biocompatible. The expandable supportive graft can be expanded from a smaller diameter insertion configuration to a larger diameter implantation configuration by the application of radially outwardly directed forces provided by expanding the endoprosthesis with a balloon catheter, using an ejection tube that allows a spring-into-place structure to be deployed from the end of a catheter into its expanded configuration, or by using a support component made of certain alloys exhibiting thermotransition characteristics by which they expand when heated, for example.
  • In addition to the support component structures illustrated herein, support structures include others having spring characteristics and those having a coil with circumferentially oriented fingers such as shown in Gianturco U.S. Pat. No. 4,800,882, incorporated by reference hereinto. U.S. Pat. Nos. 5,061,275, 5,219,355 and 5,336,500 relate to expanding or self-expanding endoluminal devices. Typically, these devices center on the use of a metallic structure imparting expansion attributes. U.S. Pat. Nos. 4,994,071 and 5,360,443 describe bifurcated devices which use expandable metallic stent structures and textile materials allowing branching of fluid flow. In general, materials of these patents, incorporated by reference hereinto, can be utilized in constructing components of the present invention.
  • More specifically, the tubular supportive component preferably is a braided tubular stent body made of metal alloy or any other material that is flexible, while being rigid and resilient when thus braided. Spring-type metals are typically preferred, such as stainless steel, titanium, stainless steel alloys, cobalt-chromium alloys, including alloys such as Elgiloy, Phynox and Conichrome. Thermal transition or memory function alloys such as nickel-titanium alloys including Nitinol are also suitable. Malleable metals including tantalum would be especially suitable for a structure that is not self-expanding.
  • Concerning the materials for the liner(s), they are typically polymeric materials in the form of a membrane or textile-like material, the objective being to reduce the porosity of the stent for proper tissue ingrowth and fluid tightness. Exemplary polymeric materials include polyesters such as polyethylene terephthalate, polyolefins such as polypropylene, or elastomeric materials such as polyurethane or silicone rubber. Combinations of these materials are also possible. In an especially preferred arrangement, the exterior liner which engages the tubular supportive component 121, when provided, is made of a double tricot polyester mesh knit, typically a Dacron type of material, while the interior liner 122 c is made of a polyurethane. In an especially preferred arrangement, a thin coating or cover of polymer is provided over the braided wires of the tubular supportive component.
  • With further reference to the material out of which the cover and/or liner of the grafts in accordance with the present invention are made, the material must be stretchable with respect to the support component so that it will follow the movement of the endoprosthesis between its fully collapsed and expanded or implanted configurations. Polyurethanes are preferred. Particularly preferred is an especially crack-resistant, elastomeric and pliable polycarbonate urethane as described in Pinchuk U.S. Pat. Nos. 5,133,742 and 5,229,431, incorporated by reference hereinto.
  • In addition, various surface treatments can be applied to render the surfaces of the expandable supported graft more biocompatible. Included are the use of pyrolytic carbon, hydrogels and the like. The surface treatments can also provide for the elution or immobilization of drugs such as heparin, antiplatelet agents, antiplatelet-derived growth factors, antibiotics, steroids, and the like. Additionally, the coating and/or liner can be loaded with drugs such as those discussed herein, as well as lytic agents in order to provide local drug therapy.
  • It will be noted that the indent(s) such as indents 124, 125 and the seams(s) such as internal seam 126 c are longitudinally disposed and generally define at least two leg portions, each with a diameter less than the diameter of the main body. Each indent has an internal longitudinal surface such as longitudinal edge 128, 129. These edges can be in contact with one another. If desired, they can be secured together such as with sutures, adhesives, wires, clips or the like (not shown). One or two such indents or creases produce an asymmetrical or a symmetrical bifurcation as desired. In another exemplary approach, three indents would form a trifurcated device. Additional creases can be provided insofar as is allowable by the braided wire mesh density and diameter.
  • Seam 126 c can be formed by joining together two or more longitudinal portions of the liner 122 c. When two such longitudinal portions are joined together, they are generally opposite to each other. When three such longitudinal portions are joined together, they are approximately 120° from each other along the circumference of the liner 122 c, and three legs are formed. When four such longitudinal portions are joined together, for example, they are spaced approximately 90° apart.
  • Whatever the number of indents or seams, the deformation of the braided tubular body reduces the cross-sectional area from that of the main trunk body to that of each branched area. The total cross-sectional area of the branching tubular bodies should be equal to or greater than 40% of the cross-sectional area of the main trunk body. Preferably, this area should be greater than about 70% in order to prevent any significant pressure differences along the device once deployed and implanted. For example, in a typical human, the cross-sectional area of the abdominal aorta is reduced by only about 20% when opening into the common iliac arteries.
  • FIG. 26 illustrates a fixture suitable for use in forming the indent or indents as permanent deformations of the braided mesh cylinder which is the tubular supportive component for this embodiment. Fixture 131 in the configuration as illustrated is used for shaping a symmetrical bifurcated design. The braided cylinder is longitudinally compressed and placed over the mandrel 132, this placement being generally shown in FIG. 27. End caps 133, 134 lock the tubular supportive component 121 in its compressed state. Same is then placed into the fixture 131, as generally shown in FIG. 26. Slits 135 are positioned parallel to the longitudinal axis and on opposite sides. This permits the slipping of blades 136, 137 into the fixture 131 and thus into engagement with the tubular supportive component. Edges 138, 139 of the blades then engage and crease the tubular supportive component 121 between the blade edges 138, 139 and the troughs 141, 142 of the mandrel 132.
  • It will be appreciated that the length of the blade edges 138, 139 can be varied in order to create a desired length of deformation on the main body of the trunk component. In addition, branching areas thus formed can be made of different sizes by varying the size of the individual cylindrical components of the mandrel 132 so they are not identical as shown in FIG. 26. A larger sized mandrel cylinder will result in the formation of a larger trunk component leg 109, 113. This would typically also include shifting the location of the slits 135 so that the plane of blade insertion will line up with the troughs. It will be appreciated that the trifurcated arrangement is achieved by a three-component mandrel and three slits and blades that are 120° apart. Similarly, a four-branched structure would include four of each features, spaced 90° apart.
  • In a preferred arrangement for this embodiment, the thus deformed braided tubular supportive component is chemically and heat processed in order to set the desired diameter and mechanical properties of the main body. Once this flexible metallic stent with conformed shape is thus prepared, it is preferably lined as discussed elsewhere herein. It will be noted that the illustrated tubular braided mesh has a main cross-sectional area and has an outward flair at both ends. The braided structure is advantageously accommodated by the serrated structure of the blade edges 138, 139 in that the wire elements of the braid are grasped and secured at the ends of the bifurcation.
  • The expandable supportive graft of the present invention is capable of being tailored to meet specific needs, depending upon the particular defect or disease being addressed, such as occlusion, stenosis, aneurysm, arteriovenosis fistula, trauma and the like, as well as upon the anatomy of the vessel. For example, it can be desirable to have the support component of the expandable supportive graft at locations other than throughout the entirety of the graft as specifically illustrated in FIGS. 1 through 4 hereof. The bifurcated graft of FIGS. 7 and 8 shows some separation along the support component, such as between the trunk 61 and the branches 62, 63. It is also possible, with the grafts in accordance with the present invention, to provide an expandable graft having its supportive property emanating from one or more support components, while thereby providing an adjoining graft cylindrical portion which is supported primarily by its close proximity to a support component which can be presented at one end, both ends, or spaced along the expandable supportive graft in accordance with the invention.
  • Such a structure is generally illustrated in FIG. 5, wherein an adjoining graft cylindrical portion 71 is positioned between a first support component 72 and another or second support component 73. The expandable supportive graft in accordance with the present invention provides the tailorability advantage of being able to vary within a single graft the configuration, structure and properties of the support component or components of the graft. These various properties allow the expandable supportive graft to be tailored in accordance with particular needs of the disease, defect or damage being treated. For example, support may be particularly desirable at one location being treated, while a less rigid supportive area is needed at another, generally adjoining location. By the expandable supportive graft in accordance with this invention, a single graft can be deployed in order to effect two or more different functions. By achieving multiple support and/or repair functions with a single device, possible trauma to the patient is minimized by reducing the number of transluminal passages needed to address a situation that could otherwise require separate stents or grafts, each of which is separately deployed or implanted.
  • With further reference to the tailorability aspects, the present invention reduces the risk of compromising the patency of the passageways being treated. This is particularly true in treating lesions at or near vascular bifurcations, branches and/or anastomoses. Typical difficulties which can be avoided by the present invention include displacing of diseased tissue, vessel spasm, dissection with or without intimal flaps, thrombosis, embolism, and the like. Another suitable use is for dilating and/or supporting vascular graft bifurcations and the like. Additionally, lesions affecting vascular trifurcations can be treated. Also treatable are obstructed openings characterized by exaggerated cicatrization, abnormal cellular growth (subintimal fibromuscular hyperplasia and the like) or arterial or venous stenosis. Moreover, these supportive grafts can be used to reinforce vascular walls, weakened by pathological processes, for example, by dissection, as in the case of aneurysms. The grafts can also obliterate congenital or acquired arteriovenous communications, and they can be applied in intrahepatic portal-caval shunts. The grafts also can maintain biological pathways open, such as the digestive, biliary, pancreatic and urinary tracts, and they help to limit the intraluminal growth of pathological processes such as fibrosis or cancer.
  • EXAMPLE I
  • This example illustrates the formation of a branched expandable supportive endoluminal graft having an expanded internal diameter of 10 mm and which is bifurcated to accommodate two endoluminal supportive graft legs of 5 to 7 mm in diameter. A liner of non-woven polycarbonate urethane (Corethane®) was spun by winding over a mandrel, generally in accordance with U.S. Pat. No. 4,475,972. In this instance, the liner consisted of approximately 400 layers of fibers. A bifurcated braided mesh tubular supportive component made in a fixture as illustrated in FIG. 26 was spray coated using a dilute solution of polycarbonate urethane having a hardness grade and a melting point lower than that used to spin the liner. It was allowed to dry with warm air. Several spray coats allow for the formation of an adhesive layer.
  • The previously prepared polycarbonate urethane liner was cut to length and placed inside the adhesive-coated bifurcated braided mesh and seated to closely fit the bifurcated braided mesh. A mandrel having a shape similar to the inner configuration of the bifurcated mesh was inserted from one end to act as a support. Shrink tubing was slipped over portions of this assembly. This assembly was heated to the melting point of the polycarbonate urethane adhesive while allowing the shrink tubing to heat shrink and compress the braided mesh against the liner which is supported by the shaped mandrel. After cooling, the shrink tubing was removed and the mandrel slipped out, leaving a completed trunk component as described herein.
  • The two endoluminal tubular expandable supportive graft leg components are prepared in accordance with a similar procedure which is simpler because of the cylindrical shape of these components.
  • EXAMPLE II
  • The procedure of Example I is substantially repeated, except the liner is a double tricot polyester mesh net. In a similar arrangement, a trunk component of the same structure was formed, except prior to insertion of the supporting mandrel, a second, innermost liner of polycarbonate urethane is positioned in order to provide a double-lined branched component.
  • EXAMPLE III
  • The procedures of Example I and of Example II are generally followed, except here the expanded inner diameter of the trunk component is 25 mm, and the cylindrical leg endoluminal grafts are 12-15 mm in diameter.
  • EXAMPLE IV
  • A branched vascular expandable supportive endoluminal graft was made using a 16 mm diameter, 12 cm long Wallstent® device as the support component in the following manner. A grounded 16 mm mandrel was rotated on a spinning machine at 500 RPM, and a spinnerette with 30 orifices was reciprocated along the axis of the mandrel at 13.8 inches/second while applying 40,000 volts to the spinnerette. Polycarbonate urethane, in dimethyl acetamide solution (45% solids) was extruded from the spinnerette at 0.123 ml/min, the fibers coming onto the mandrel in random fashion to form a mat-like structure having randomly shaped pores. The environment in the spinning chamber was controlled such that sufficient solvent from the urethane solution evaporated off during spinning to enable the fibers to be bond to underlying fibers during each transverse of the spinnerette. After 300 passes of the spinnerette, the spinning procedure was stopped and the mandrel with the spun polycarbonate urethane mat was removed from the machine and cured at 110° C. for 16 hours. The tubular mat still on the mandrel was trimmed to the appropriate size and the Wallstent® device was sheathed over the mesh and the ends taped down. Another 10 passes of polycarbonate urethane were spun over the Wallstent® device, and the fibers, while still wet, are immediately pressed through the interstices of the Wallstent® device with a silicone rubber sponge at selected longitudinal locations, such that the fibers bond to the underlying fibers of the urethane mat, thereby capturing the Wallstent® device within the urethane wall along those longitudinal locations. The assembly is then cured for an additional 3 hours at 110° C., after which the assembly is removed from the mandrel. The expandable supportive endoluminal graft formed in this manner had the bulk of the urethane mesh on the inside of the stent. The longitudinal locations which are not secured to the stent are joined together to form a seam to define two legs as generally shown in FIG. 31.
  • EXAMPLE V
  • A branched aortic expandable supportive endoluminal graft is made in the following manner. An aortic trunk supportive endoluminal graft is fabricated using a 16 mm diameter, 12 cm long support component. First, a 16 mm mandrel is rotated on a spinning machine at 500 rpm, and a spinnerette with 30 orifices reciprocated along the axis of the mandrel at 13.8 inches/second. Polycarbonate urethane, in dimethyl acetamide solution (45% solids) is extruded from the spinnerette at 0.123 ml/min and wound onto the rotating mandrel such that the fibers form a 50° pitch angle in relation to the axis of the mandrel. The environment in the spinning chamber is controlled such that sufficient solvent from the urethane solution evaporates off during spinning to enable the fibers to bond to underlying fibers during each transverse of the spinnerette. The formed spun polycarbonate urethane mesh has a length of about 16 cm, is removed from the machine and is cured at 110° C. for 16 hours. The support component is sheathed over the mesh still on the mandrel. Another 10 passes of polycarbonate urethane are spun over the tubular mesh, support component, but not over the 4 cm excess length of the internal tubular mesh, and the fibers, while still wet, are immediately pressed through the interstices of the support component with a silicone rubber sponge, such that the fibers bonded to the underlying fibers of the urethane mesh, thereby capturing the support component within the urethane wall. The assembly is then cured for an additional 3 hours at 110° C., after which the assembly is removed from the mandrel. The supportive endoluminal graft formed in this manner has fiber diameters of 10 to 20μ and pore sizes ranging from 10 to 60μ. The length of the tubular mesh which is spaced about 4 cm from each side of the assembled endoprosthesis is then slit and sewn down the center such that the tube is branched into two smaller tubes along about 8 cm of the longitudinal central length of the tubular mesh.
  • The aortic trunk endoprosthesis is pulled down and sheathed on an introducer catheter, maneuvered into the aorta of a dog, via the dog's femoral artery for deployment in the abdominal aorta. Two smaller stents, of 8 mm diameter, are also pulled down onto introducer catheters and maneuvered, through each femoral artery for deployment into the seam-defined two smaller tubes or “legs” of the aortic trunk. The resultant branched endoprosthesis is for limiting further dilation of an abdominal-iliac aneurysm.
  • EXAMPLE VI
  • A branched expandable supportive endoluminal graft is provided for deployment within and repair of aorto-iliac aneurysms. A generally tubular metallic stent of the self-expandable type is adhered to the outside of a porous spun liner as follows. The graft is wound or spun from filaments deposited onto a rotating mandrel in order to form a cylindrical graft having crossing strands generally adhered together. The resulting inner liner, after it is dried, has a stent component placed over it. Then, an area of the stent is masked, such as with a piece of tape, at the location where an internal seam is to be positioned in the trunk component of the supportive endoluminal graft. The masking can take on a shape on the order of the triangular areas illustrated in FIG. 32, with the upper apex forming the upper “crotch” of the seam, and the lower apex forming the lower “crotch” of the seam. Additional fibers are then spun over the entire stent and pressed through the stent intersticies to be certain that the stent is secured to the liner. This continues until all areas of the stent are well-bonded except for the masked areas. After removal of the mandrel and of the masking material, the initially formed inner liner is free to be pinched along its length and sutured, sewed and/or glued and the like to form two distinct leg portions and a trunk portion of the liner. The resulting trunk component is as generally shown in FIGS. 31 and 32.
  • The leg components of the branched supportive endoluminal graft in accordance with this Example are individually made in a similar manner. The liner is formed by spinning compliant fibers over a rotating mandrel, a tubular stent component is positioned thereover and secured in place, and additional fibers are wound with the rotating mandrel. The stent is thus encapsulated between the liner fibers and the cover fibers, preferably with the aid of a soft roller or sponge to force the cover strands into the interstices of the stent component and securement to the underlying liner fibers. After removal from the mandrel, the resulting tubular supported graft component, suitable for use as both the iliac components, is trimmed to proper length.
  • EXAMPLE VII
  • A branched aortic expandable supportive endoluminal graft was made using a liner of polycarbonate urethane. The cylindrical liner was flattened, and a longitudinal seam was formed by heat sealing together the flattened opposing portions along a thus formed seal line. A self-expanding cylindrical stent-like support component was coated on at least its inside surface with a heat-activated adhesive. The seamed liner was inserted into the stent-like support component, and the liner was inflated until the two non-seamed portions of the liner and the radially extending portions of the seamed portion of the liner engaged the inner surface of the support component. Then, this assembly with the inflated liner was placed into an oven to activate the adhesive whereby, upon subsequent cooling, the seamed liner was secured to the support component to form a branched trunk component as shown in FIGS. 31 and 32. In this example, the inflation of the liner was carried out by packing the seamed liner with salt crystals so the liner stretches in place and until adhesion between the liner and the support component had occurred.
  • EXAMPLE VIII
  • A branched trunk component is prepared as described in Example VII, except the liner inflation is carried out by expanding balloon activity, and the seam is formed by suturing. Because the branched trunk component will elongate when collapsed for entry into the delivery tool, the suturing allows for longitudinal expansion and contraction back down to the as-manufactured seam length. Such suturing is achieved by using a zig-zag stitch pattern.
  • EXAMPLE IX
  • Another branched trunk component is made as described in Example VIII, except the liner inflation is carried out by a mandrel, and the sutured seam is formed with a polyurethane compliant suture material.
  • It will be understood that the embodiments of the present invention which have been described are illustrative of some of the applications of the principles of the present invention. Various modifications may be made by those skilled in the art without departing from the true spirit and scope of the invention.

Claims (17)

1-42. (canceled)
43. An endoluminal support device comprising:
a radially-expandable, bifurcated support, the support including:
a first support portion, and
a second support portion including a first lobe and a second lobe, and a longitudinal isthmus between the first lobe and the second lobe,
the first and second lobes having smaller diameters than the first portion; and
a liner coupled to the radially-expandable, bifurcated support,
wherein the endoluminal support device has an uninterrupted cross-section over its entire length.
44. The endoluminal support device of claim 43, wherein the liner is coupled to an interior side of the radially-expandable, bifurcated support.
45. The endoluminal support device of claim 43, wherein the liner is coupled to an exterior side of the radially-expandable, bifurcated support.
46. The endoluminal support device of claim 43, wherein each of the first and second lobes is adapted to receive a branch support.
47. A branching endovascular prosthesis comprising:
a radially expandable support, the support including:
a distal support portion comprising at least one expandable circumferential portion, and
a proximal support portion including a first lobe and a second lobe separated from the first lobe by an isthmus, and
a bifurcated liner coupled to the distal support portion and to the proximal support portion,
wherein the branching endovascular prosthesis has an uninterrupted cross-section over its entire length.
48. The prosthesis of claim 47, wherein the bifurcated liner is coupled to an interior side of the distal support portion and to an interior side of the proximal support portion.
49. The prosthesis of claim 47, wherein the bifurcated liner is coupled to an exterior side of the distal support portion and to an exterior side of the proximal support portion.
50. The prosthesis of claim 47, wherein the prosthesis is self expanding.
51. A branching endovascular prosthesis comprising:
a distal support portion comprising at least one radially expandable portion;
a proximal support portion coupled to the distal support portion, the proximal support portion including a first radially expandable lobe and a second radially expandable lobe separated from the first lobe by an isthmus; and
a bifurcated liner coupled to the distal support portion and to the proximal support portion,
wherein the branching endovascular prosthesis has an uninterrupted cross-section over its entire length.
52. The prosthesis of claim 51, wherein the bifurcated liner is coupled to an interior side of the distal support portion and to an interior side of the proximal support portion.
53. The prosthesis of claim 51, wherein the bifurcated liner is coupled an exterior side of the distal support portion and to an exterior side of the proximal support portion.
54. A branching endoluminal prosthesis comprising:
a liner and a radially expandable support coupled to said liner;
wherein said liner comprises:
a main body having a proximal portion and a distal portion, said proximal portion including a main lumen, and said distal portion including a first branch having a first lumen extending to a first distal end, and a second branch having a second lumen extending to a second distal end, the first and second branch lumens being in communication with the main lumen and extending through said distal portion to define a bifurcation extending to said first and second distal ends; and
wherein said support comprises:
a distal support portion disposed over said distal portion of said main body, said distal support portion comprising at least one expandable circumferential portion defining a first lobe supporting said first branch, a second lobe supporting said second branch, and opposed indentations to support and separate said first and second branches,
wherein said branching endoluminal prosthesis has an uninterrupted cross-section over its entire length.
55. The branching endoluminal prosthesis of claim 54 wherein said support further comprises an expandable proximal circumferential portion supporting said proximal portion of said main body.
56. The branching endoluminal prosthesis of claim 54 further comprising an attachment mechanism which couples said distal support to said distal portion of said main body of said liner.
57. The branching endoluminal prosthesis of claim 56 wherein said attachment mechanism attaches said first lobe and a portion of each indentation to the first branch.
58. The branching endoluminal prosthesis of claim 57 wherein said attachment mechanism attaches said second lobe and a portion of each indentation to the second branch.
US11/906,703 1993-10-21 2007-10-03 Expandable supportive branched endoluminal grafts Abandoned US20090138067A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/906,703 US20090138067A1 (en) 1993-10-21 2007-10-03 Expandable supportive branched endoluminal grafts

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US14024593A 1993-10-21 1993-10-21
US08/558,028 US5632772A (en) 1993-10-21 1995-11-13 Expandable supportive branched endoluminal grafts
US08/558,034 US5639278A (en) 1993-10-21 1995-11-13 Expandable supportive bifurcated endoluminal grafts
US08/863,964 US5855598A (en) 1993-10-21 1997-05-27 Expandable supportive branched endoluminal grafts
US65704100A 2000-09-05 2000-09-05
US11/906,703 US20090138067A1 (en) 1993-10-21 2007-10-03 Expandable supportive branched endoluminal grafts

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US65704100A Division 1993-10-21 2000-09-05

Publications (1)

Publication Number Publication Date
US20090138067A1 true US20090138067A1 (en) 2009-05-28

Family

ID=24227879

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/558,028 Expired - Lifetime US5632772A (en) 1993-10-21 1995-11-13 Expandable supportive branched endoluminal grafts
US11/906,703 Abandoned US20090138067A1 (en) 1993-10-21 2007-10-03 Expandable supportive branched endoluminal grafts

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US08/558,028 Expired - Lifetime US5632772A (en) 1993-10-21 1995-11-13 Expandable supportive branched endoluminal grafts

Country Status (10)

Country Link
US (2) US5632772A (en)
EP (4) EP1348403B1 (en)
JP (1) JP3442081B2 (en)
AT (2) ATE422861T1 (en)
AU (1) AU710862B2 (en)
CA (1) CA2234976C (en)
DE (4) DE69637839D1 (en)
DK (1) DK0883384T3 (en)
ES (3) ES2322893T3 (en)
WO (1) WO1997017913A1 (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050288790A1 (en) * 2003-04-16 2005-12-29 Porex Surgical, Inc Craniofacial implant
US20060224242A1 (en) * 2003-04-16 2006-10-05 Porex Surgical, Inc. Craniofacial implant
US20100063575A1 (en) * 2007-03-05 2010-03-11 Alon Shalev Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US20100070019A1 (en) * 2006-10-29 2010-03-18 Aneuwrap Ltd. extra-vascular wrapping for treating aneurysmatic aorta and methods thereof
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
US20140058526A1 (en) * 2012-08-22 2014-02-27 Biomet Manufacturing Corporation Directional porous coating
US8858613B2 (en) 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods
US8870938B2 (en) 2009-06-23 2014-10-28 Endospan Ltd. Vascular prostheses for treating aneurysms
US20150005869A1 (en) * 2012-02-14 2015-01-01 Neograft Technologies, Inc. Kink Resistant Graft Devices and Related Systems and Methods
US8945203B2 (en) 2009-11-30 2015-02-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US8951298B2 (en) 2011-06-21 2015-02-10 Endospan Ltd. Endovascular system with circumferentially-overlapping stent-grafts
US8956397B2 (en) 2009-12-31 2015-02-17 Endospan Ltd. Endovascular flow direction indicator
US8979892B2 (en) 2009-07-09 2015-03-17 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US20150126997A1 (en) * 2010-10-20 2015-05-07 Medtronic Ardian Luxembourg S.A.R.L. Catheter Apparatuses Having Expandable Mesh Structures for Renal Neuromodulation and Associated Systems and Methods
US9044195B2 (en) 2013-05-02 2015-06-02 University Of South Florida Implantable sonic windows
US9101457B2 (en) 2009-12-08 2015-08-11 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
US9132025B2 (en) 2012-06-15 2015-09-15 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US9486341B2 (en) 2011-03-02 2016-11-08 Endospan Ltd. Reduced-strain extra-vascular ring for treating aortic aneurysm
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9572652B2 (en) 2009-12-01 2017-02-21 Altura Medical, Inc. Modular endograft devices and associated systems and methods
US9597204B2 (en) 2011-12-04 2017-03-21 Endospan Ltd. Branched stent-graft system
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9737426B2 (en) 2013-03-15 2017-08-22 Altura Medical, Inc. Endograft device delivery systems and associated methods
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US9839510B2 (en) 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US20180221146A1 (en) * 2017-02-03 2018-08-09 Mayo Foundation For Medical Education And Research Methods for making nanofibrous coverings for implantable medical devices
WO2018200972A1 (en) * 2017-04-28 2018-11-01 Regents Of The University Of Minnesota Compliant aortic stent grafts and related systems and methods
US10285833B2 (en) 2012-08-10 2019-05-14 Lombard Medical Limited Stent delivery systems and associated methods
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
US10485684B2 (en) 2014-12-18 2019-11-26 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking

Families Citing this family (339)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006440A3 (en) * 1992-12-21 1994-08-30 Dereume Jean Pierre Georges Em Luminal endoprosthesis AND METHOD OF PREPARATION.
US5843167A (en) * 1993-04-22 1998-12-01 C. R. Bard, Inc. Method and apparatus for recapture of hooked endoprosthesis
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
DE69419877T2 (en) * 1993-11-04 1999-12-16 Bard Inc C R Fixed vascular prosthesis
US6165213A (en) 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
DE29522101U1 (en) 1994-06-08 1999-12-09 Cardiovascular Concepts Inc Endoluminal prosthesis
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US6193745B1 (en) 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6348066B1 (en) * 1995-11-07 2002-02-19 Corvita Corporation Modular endoluminal stent-grafts and methods for their use
US6576009B2 (en) 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US6042605A (en) 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
EP0950385A3 (en) 1995-12-14 1999-10-27 Prograft Medical, Inc. Stent-graft deployment apparatus and method
US5843160A (en) * 1996-04-01 1998-12-01 Rhodes; Valentine J. Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen
BE1010183A3 (en) * 1996-04-25 1998-02-03 Dereume Jean Pierre Georges Em Luminal endoprosthesis FOR BRANCHING CHANNELS OF A HUMAN OR ANIMAL BODY AND MANUFACTURING METHOD THEREOF.
FR2749500B1 (en) * 1996-06-06 1998-11-20 Jacques Seguin DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION
US7686846B2 (en) 1996-06-06 2010-03-30 Devax, Inc. Bifurcation stent and method of positioning in a body lumen
US7238197B2 (en) * 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
US8728143B2 (en) * 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
US6666883B1 (en) 1996-06-06 2003-12-23 Jacques Seguin Endoprosthesis for vascular bifurcation
US6312454B1 (en) * 1996-06-13 2001-11-06 Nitinol Devices & Components Stent assembly
CN1166346C (en) * 1996-06-20 2004-09-15 瓦斯卡泰克有限公司 Prosthetic repair of body passages
US7193124B2 (en) 1997-07-22 2007-03-20 Battelle Memorial Institute Method for forming material
US7341598B2 (en) * 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US5976178A (en) * 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US5941908A (en) * 1997-04-23 1999-08-24 Vascular Science, Inc. Artificial medical graft with a releasable retainer
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US6352561B1 (en) 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
BE1010858A4 (en) * 1997-01-16 1999-02-02 Medicorp R & D Benelux Sa Luminal endoprosthesis FOR BRANCHING.
US5957974A (en) * 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
JP4042998B2 (en) 1997-01-29 2008-02-06 クック インコーポレイテッド Bell bottom modular stent graft
US6090128A (en) * 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
US6951572B1 (en) 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
US6302908B1 (en) * 1997-03-24 2001-10-16 Juan Carlos Parodi Arterial graft device and method of positioning the same
CA2424551A1 (en) * 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US5906641A (en) * 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft
US6723121B1 (en) * 1997-06-18 2004-04-20 Scimed Life Systems, Inc. Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
DE69839077T2 (en) * 1997-06-18 2009-01-22 Boston Scientific Ltd., St. Michael POLYCARBONATE POLYURETHANE DISPERSION AS A DUST-RESISTANT COATING
US5957940A (en) * 1997-06-30 1999-09-28 Eva Corporation Fasteners for use in the surgical repair of aneurysms
US5997556A (en) * 1997-06-30 1999-12-07 Eva Corporation Surgical fastener
US5899935A (en) * 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6165195A (en) 1997-08-13 2000-12-26 Advanced Cardiovascylar Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6361544B1 (en) 1997-08-13 2002-03-26 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6187033B1 (en) 1997-09-04 2001-02-13 Meadox Medicals, Inc. Aortic arch prosthetic graft
US6306164B1 (en) * 1997-09-05 2001-10-23 C. R. Bard, Inc. Short body endoprosthesis
US6254627B1 (en) 1997-09-23 2001-07-03 Diseno Y Desarrollo Medico S.A. De C.V. Non-thrombogenic stent jacket
CA2304553C (en) * 1997-09-23 2008-06-17 Carlos Vonderwalde Freidberg Bifurcated stent with flexible side portion
US6371982B2 (en) 1997-10-09 2002-04-16 St. Jude Medical Cardiovascular Group, Inc. Graft structures with compliance gradients
US6241691B1 (en) 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6168570B1 (en) 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6048362A (en) * 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
FR2775182B1 (en) * 1998-02-25 2000-07-28 Legona Anstalt DEVICE FORMING INTRACORPOREAL ENDOLUMINAL ANDOPROTHESIS, IN PARTICULAR AORTIC ABDOMINAL
US6235054B1 (en) 1998-02-27 2001-05-22 St. Jude Medical Cardiovascular Group, Inc. Grafts with suture connectors
US6077296A (en) * 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US6099497A (en) * 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US7491232B2 (en) 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution
US6524336B1 (en) * 1998-04-09 2003-02-25 Cook Incorporated Endovascular graft
US6364856B1 (en) * 1998-04-14 2002-04-02 Boston Scientific Corporation Medical device with sponge coating for controlled drug release
US6099559A (en) * 1998-05-28 2000-08-08 Medtronic Ave, Inc. Endoluminal support assembly with capped ends
WO1999065419A1 (en) * 1998-06-19 1999-12-23 Endologix, Inc. Self expanding bifurcated endovascular prosthesis
US6217609B1 (en) 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US6656218B1 (en) * 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US6165194A (en) 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US20020173839A1 (en) * 1998-07-24 2002-11-21 Leopold Eric W. Intravascular flow modifier and reinforcement device with connected segments
US6143022A (en) * 1998-08-24 2000-11-07 Medtronic Ave, Inc. Stent-graft assembly with dual configuration graft component and method of manufacture
US6755856B2 (en) * 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US7815763B2 (en) 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6682554B2 (en) * 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US6849088B2 (en) * 1998-09-30 2005-02-01 Edwards Lifesciences Corporation Aorto uni-iliac graft
AUPQ302999A0 (en) * 1999-09-23 1999-10-21 Endogad Research Pty Limited Pre-shaped intraluminal graft
US6368345B1 (en) * 1998-09-30 2002-04-09 Edwards Lifesciences Corporation Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat
US6475222B1 (en) * 1998-11-06 2002-11-05 St. Jude Medical Atg, Inc. Minimally invasive revascularization apparatus and methods
US6508252B1 (en) 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
US6197049B1 (en) 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
DE69927055T2 (en) 1998-12-11 2006-06-29 Endologix, Inc., Irvine ENDOLUMINAL VASCULAR PROSTHESIS
US20020065546A1 (en) * 1998-12-31 2002-05-30 Machan Lindsay S. Stent grafts with bioactive coatings
US20050171594A1 (en) * 1998-12-31 2005-08-04 Angiotech International Ag Stent grafts with bioactive coatings
US8257425B2 (en) * 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
CA2329213C (en) * 1999-01-22 2005-08-09 Gore Enterprise Holdings, Inc. Low profile stent and graft combination
JP2003525065A (en) * 1999-01-27 2003-08-26 ボストン サイエンティフィック リミテッド Bifurcation stent delivery system
US6162246A (en) * 1999-02-16 2000-12-19 Barone; Hector Daniel Aortic graft and method of treating abdominal aortic aneurysms
EP1161185A2 (en) * 1999-03-09 2001-12-12 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
DE19923133B4 (en) * 1999-05-19 2007-07-05 Neuß, Malte, Dipl.-Ing. (FH) Dr.med. Radially expandable vascular support
WO2000071053A1 (en) * 1999-05-19 2000-11-30 Eurocor Gmbh Radially expandable vessel support
US6699256B1 (en) 1999-06-04 2004-03-02 St. Jude Medical Atg, Inc. Medical grafting apparatus and methods
US6648913B1 (en) 1999-06-07 2003-11-18 Scimed Life Systems, Inc. Guidewire-access modular intraluminal prosthesis with connecting section
US6440161B1 (en) 1999-07-07 2002-08-27 Endologix, Inc. Dual wire placement catheter
US6371980B1 (en) * 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
AU7714500A (en) * 1999-09-23 2001-04-24 Advanced Stent Technologies, Inc. Bifurcation stent system and method
US6383213B2 (en) 1999-10-05 2002-05-07 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
AU1083101A (en) * 1999-10-12 2001-04-23 Allan R. Will Methods and devices for protecting a passageway in a body
US6325823B1 (en) 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6387120B2 (en) 1999-12-09 2002-05-14 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6398807B1 (en) * 2000-01-31 2002-06-04 Scimed Life Systems, Inc. Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
US6602280B2 (en) * 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US8092511B2 (en) * 2000-03-03 2012-01-10 Endovascular Technologies, Inc. Modular stent-graft for endovascular repair of aortic arch aneurysms and dissections
US6814752B1 (en) 2000-03-03 2004-11-09 Endovascular Technologies, Inc. Modular grafting system and method
US6942691B1 (en) 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
US7135037B1 (en) 2000-05-01 2006-11-14 Endovascular Technologies, Inc. System and method for forming a junction between elements of a modular endovascular prosthesis
US7666221B2 (en) * 2000-05-01 2010-02-23 Endovascular Technologies, Inc. Lock modular graft component junctions
US8252044B1 (en) 2000-11-17 2012-08-28 Advanced Bio Prosthestic Surfaces, Ltd. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US20030139803A1 (en) * 2000-05-30 2003-07-24 Jacques Sequin Method of stenting a vessel with stent lumenal diameter increasing distally
US6582394B1 (en) 2000-11-14 2003-06-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcated vessels
US20020124851A1 (en) * 2000-11-28 2002-09-12 Richard Knauer Hearing protective device and method of making same
US6544219B2 (en) 2000-12-15 2003-04-08 Advanced Cardiovascular Systems, Inc. Catheter for placement of therapeutic devices at the ostium of a bifurcation of a body lumen
US20020084178A1 (en) * 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US20040030377A1 (en) * 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
US20070031607A1 (en) * 2000-12-19 2007-02-08 Alexander Dubson Method and apparatus for coating medical implants
WO2002067815A1 (en) 2001-02-26 2002-09-06 Scimed Life Systems, Inc. Bifurcated stent
US7799064B2 (en) 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
AU2002250189A1 (en) * 2001-02-26 2002-09-12 Scimed Life Systems, Inc. Bifurcated stent and delivery system
EP1377421A4 (en) * 2001-03-20 2004-05-26 Nicast Ltd Polymer fiber tubular structure having improved kinking resistance
US20040131673A1 (en) * 2001-03-22 2004-07-08 Coffee Ronald Alan Manufacturing dissolvable dosage forms
US6761733B2 (en) * 2001-04-11 2004-07-13 Trivascular, Inc. Delivery system and method for bifurcated endovascular graft
US6733521B2 (en) 2001-04-11 2004-05-11 Trivascular, Inc. Delivery system and method for endovascular graft
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US6749628B1 (en) 2001-05-17 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
WO2003045283A1 (en) * 2001-11-28 2003-06-05 Aptus Endosystems, Inc. Endovascular aneurysm repair system
US6929661B2 (en) * 2001-11-28 2005-08-16 Aptus Endosystems, Inc. Multi-lumen prosthesis systems and methods
US20070073389A1 (en) 2001-11-28 2007-03-29 Aptus Endosystems, Inc. Endovascular aneurysm devices, systems, and methods
US20110087320A1 (en) * 2001-11-28 2011-04-14 Aptus Endosystems, Inc. Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis Assembly
US8231639B2 (en) 2001-11-28 2012-07-31 Aptus Endosystems, Inc. Systems and methods for attaching a prosthesis within a body lumen or hollow organ
US9320503B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Devices, system, and methods for guiding an operative tool into an interior body region
US20050177180A1 (en) 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US20050121411A1 (en) * 2002-10-29 2005-06-09 Microfabrica Inc. Medical devices and EFAB methods and apparatus for producing them
US7014653B2 (en) * 2001-12-20 2006-03-21 Cleveland Clinic Foundation Furcated endovascular prosthesis
US7125464B2 (en) * 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US20100016943A1 (en) 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7029482B1 (en) * 2002-01-22 2006-04-18 Cardica, Inc. Integrated anastomosis system
WO2003071929A2 (en) * 2002-02-26 2003-09-04 Endovascular Technologies, Inc. Endovascular grafting device
US20030216804A1 (en) * 2002-05-14 2003-11-20 Debeer Nicholas C. Shape memory polymer stent
US6802859B1 (en) 2002-07-12 2004-10-12 Endovascular Technologies, Inc. Endovascular stent-graft with flexible bifurcation
US7122051B1 (en) 2002-07-12 2006-10-17 Endovascular Technologies, Inc. Universal length sizing and dock for modular bifurcated endovascular graft
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
US11890181B2 (en) * 2002-07-22 2024-02-06 Tmt Systems, Inc. Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
EP1550477B1 (en) 2002-08-23 2015-11-04 National Cerebral and Cardiovascular Center Stent and process for producing the same
US20040167597A1 (en) * 2002-10-23 2004-08-26 Costantino Peter D. Aneurysm treatment devices and methods
EP1567087B1 (en) 2002-11-08 2009-04-01 Jacques Seguin Endoprosthesis for vascular bifurcation
US20040199241A1 (en) * 2002-12-30 2004-10-07 Angiotech International Ag Silk stent grafts
US8535370B1 (en) 2003-01-23 2013-09-17 Endovascular Technologies, Inc. Radiopaque markers for endovascular graft alignment
US20040148001A1 (en) * 2003-01-24 2004-07-29 Nolting John E. Solvent-bonded stent-graft assembly
US8109987B2 (en) * 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7972372B2 (en) * 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US7758630B2 (en) * 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US7731747B2 (en) * 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US20070032852A1 (en) * 2003-04-25 2007-02-08 Medtronic Vascular, Inc. Methods and Apparatus for Treatment of Aneurysms Adjacent to Branch Arteries
US7438721B2 (en) * 2003-04-25 2008-10-21 Medtronic Vascular, Inc. Universal modular stent graft assembly to accommodate flow to collateral branches
US20040230289A1 (en) * 2003-05-15 2004-11-18 Scimed Life Systems, Inc. Sealable attachment of endovascular stent to graft
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
US20050009074A1 (en) * 2003-07-07 2005-01-13 Medtronic Vascular, Inc. Implantable monitor of vulnerable plaque and other disease states
US7959665B2 (en) 2003-07-31 2011-06-14 Abbott Cardiovascular Systems Inc. Intravascular stent with inverted end rings
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7235083B1 (en) 2003-09-10 2007-06-26 Endovascular Technologies, Inc. Methods and devices for aiding in situ assembly of repair devices
WO2005039664A2 (en) * 2003-10-14 2005-05-06 Cube Medical A/S Medical device with electrospun nanofibers
WO2005046747A2 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Intravascular devices and fibrosis-inducing agents
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7090694B1 (en) 2003-11-19 2006-08-15 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
WO2005065578A2 (en) 2004-01-06 2005-07-21 Nicast Ltd. Vascular prosthesis with anastomotic member
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US8057841B2 (en) 2004-02-12 2011-11-15 University Of Akron Mechanically attached medical device coatings
US8007528B2 (en) * 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
WO2005094725A1 (en) 2004-03-31 2005-10-13 Merlin Md Pte Ltd A method for treating aneurysms
JP2007534389A (en) * 2004-04-29 2007-11-29 キューブ・メディカル・アクティーゼルスカブ Balloon used for angiogenesis
AU2010236494B2 (en) 2004-05-25 2013-05-30 Covidien Lp Vascular stenting for aneurysms
EP1750619B1 (en) 2004-05-25 2013-07-24 Covidien LP Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8267985B2 (en) * 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
JP5054524B2 (en) 2004-06-08 2012-10-24 アドバンスド ステント テクノロジーズ, インコーポレイテッド Stent with protruding branch for branch pipe
US9427340B2 (en) * 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
CA2599035A1 (en) * 2005-02-17 2006-08-24 Nicast Ltd. Inflatable medical device
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
EP1883371B1 (en) 2005-05-25 2015-10-07 Covidien LP System and method for delivering and deploying and occluding device within a vessel
US20060271161A1 (en) * 2005-05-26 2006-11-30 Boston Scientific Scimed, Inc. Selective treatment of stent side branch petals
US8480728B2 (en) * 2005-05-26 2013-07-09 Boston Scientific Scimed, Inc. Stent side branch deployment initiation geometry
US8317855B2 (en) * 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
ES2691646T3 (en) 2005-07-15 2018-11-28 Micell Technologies, Inc. Polymer coatings containing controlled morphology drug powder
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
KR100644194B1 (en) * 2005-08-02 2006-11-10 휴메드 주식회사 Device for treatment of an aortic aneurysm
US7731741B2 (en) 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US8038706B2 (en) * 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
CN101466316B (en) 2005-10-20 2012-06-27 阿普特斯内系统公司 Devices systems and methods for prosthesis delivery and implantation including the use of a fastener tool
US20070112418A1 (en) 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US7540881B2 (en) * 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
JP4750860B2 (en) * 2006-02-13 2011-08-17 マーリン エムディー ピーティーイー リミテッド Intravascular device having a membrane
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US8821561B2 (en) 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US20070208411A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcated stent with surface area gradient
US7833264B2 (en) * 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US20070208419A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcation stent with uniform side branch projection
US8298278B2 (en) * 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
PL2019657T3 (en) 2006-04-26 2015-10-30 Micell Technologies Inc Coatings containing multiple drugs
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
US8029558B2 (en) * 2006-07-07 2011-10-04 Abbott Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
EP3360509B1 (en) 2006-07-31 2022-06-22 Syntheon TAVR, LLC Sealable endovascular implants
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9408607B2 (en) * 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US7951191B2 (en) * 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US20080097578A1 (en) * 2006-10-20 2008-04-24 Medtronic Vascular, Inc. Extender Cuff for Branch Vessel
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
US7842082B2 (en) * 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8216298B2 (en) 2007-01-05 2012-07-10 Medtronic Vascular, Inc. Branch vessel graft method and delivery system
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CN101711137B (en) 2007-01-08 2014-10-22 米歇尔技术公司 Stents having biodegradable layers
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US7959668B2 (en) * 2007-01-16 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent
US8118861B2 (en) * 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8647376B2 (en) * 2007-03-30 2014-02-11 Boston Scientific Scimed, Inc. Balloon fold design for deployment of bifurcated stent petal architecture
JP2008253297A (en) * 2007-03-30 2008-10-23 Univ Kansai Medical Medical tube
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US20090012601A1 (en) * 2007-07-05 2009-01-08 Abbott Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
US7959669B2 (en) * 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
WO2009046372A2 (en) 2007-10-04 2009-04-09 Trivascular2, Inc. Modular vascular graft for low profile percutaneous delivery
US20090105806A1 (en) * 2007-10-23 2009-04-23 Endologix, Inc Stent
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8920488B2 (en) * 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US8337544B2 (en) * 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8277501B2 (en) * 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
EP2242456A2 (en) 2007-12-31 2010-10-27 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
US20090240318A1 (en) * 2008-03-19 2009-09-24 Boston Scientific Scimed, Inc. Stent expansion column, strut and connector slit design
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
WO2009146209A1 (en) 2008-04-17 2009-12-03 Micell Technologies, Inc. Stents having bioabsorbable layers
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8932340B2 (en) * 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
WO2009149405A1 (en) 2008-06-05 2009-12-10 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
JP5662310B2 (en) 2008-06-05 2015-01-28 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Shrinkable branch device and method of manufacturing the same
WO2010002931A1 (en) 2008-07-01 2010-01-07 Endologix, Inc. Catheter system
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
CA2730995C (en) 2008-07-17 2016-11-22 Micell Technologies, Inc. Drug delivery medical device
US8900207B2 (en) * 2008-08-29 2014-12-02 Barry F. Uretsky Apparatus and method for treatment of bifurcation lesions
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
CA2739007C (en) 2008-09-25 2017-10-31 Advanced Bifurcation Systems Inc. Partially crimped stent
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8979917B2 (en) 2008-09-25 2015-03-17 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
CA2740867C (en) 2008-10-16 2018-06-12 Aptus Endosystems, Inc. Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation
JP2012522589A (en) 2009-04-01 2012-09-27 ミシェル テクノロジーズ,インコーポレイテッド Covered stent
EP2419058B1 (en) 2009-04-17 2018-02-28 Micell Technologies, Inc. Stents having controlled elution
US20100274276A1 (en) * 2009-04-22 2010-10-28 Ricky Chow Aneurysm treatment system, device and method
US20110054586A1 (en) 2009-04-28 2011-03-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
EP2424447A2 (en) 2009-05-01 2012-03-07 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US8382818B2 (en) * 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
JP5588511B2 (en) 2009-07-27 2014-09-10 エンドロジックス、インク Stent graft
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
WO2011119883A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
AU2011232360B2 (en) 2010-03-24 2015-10-08 Advanced Bifurcation Systems Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
EP2560576B1 (en) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US9707108B2 (en) 2010-11-24 2017-07-18 Tryton Medical, Inc. Support for treating vascular bifurcations
EP2672925B1 (en) 2011-02-08 2017-05-03 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
US8808350B2 (en) 2011-03-01 2014-08-19 Endologix, Inc. Catheter system and methods of using same
US20120253377A1 (en) * 2011-03-31 2012-10-04 Codman & Shurtleff, Inc. Modifiable occlusion device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US10987208B2 (en) 2012-04-06 2021-04-27 Merlin Md Pte Ltd. Devices and methods for treating an aneurysm
ITMI20120646A1 (en) * 2012-04-18 2013-10-19 Sambusseti Antonio PERMANENT TUBULAR DEVICE FOR THE RECONSTRUCTION OF A URETHRAL OR URETERAL SEGMENT MADE OF SILICONE COATED WITH TURBOSTRIC PYROLYTIC CARBON
WO2013162724A1 (en) 2012-04-26 2013-10-31 Tryton Medical, Inc. Support for treating vascular bifurcations
JP6220386B2 (en) 2012-05-14 2017-10-25 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Uniformly expandable stent
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
CA2905419C (en) 2013-03-12 2020-04-28 Micell Technologies, Inc. Bioabsorbable biomedical implants
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
AU2014265460B2 (en) 2013-05-15 2018-10-18 Micell Technologies, Inc. Bioabsorbable biomedical implants
CN105899243A (en) * 2014-02-21 2016-08-24 矽瑞奥科技公司 Vascular grafts and method for preserving patency of same
US9468545B2 (en) * 2014-04-04 2016-10-18 W. L. Gore & Associates, Inc. Bifurcated graft device
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US10905540B2 (en) 2015-11-12 2021-02-02 Endospan Ltd. Stent-grafts systems with skirt
US9987122B2 (en) 2016-04-13 2018-06-05 Medtronic Vascular, Inc. Iliac branch device and method
AR104494A1 (en) 2016-04-27 2017-07-26 Daniel Barone Hector AORTIC PROSTHETICS FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURISMS
US10869747B2 (en) 2017-05-10 2020-12-22 Cook Medical Technologies Llc Side branch aortic repair graft with wire lumen
KR102436996B1 (en) * 2017-10-25 2022-08-26 보스톤 싸이엔티픽 싸이메드 인코포레이티드 Stents with atraumatic spacers
US11324583B1 (en) 2021-07-06 2022-05-10 Archo Medical LTDA Multi-lumen stent-graft and related surgical methods

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526005A (en) * 1967-06-29 1970-09-01 Gulf General Atomic Inc Method of preparing an intravascular defect by implanting a pyrolytic carbon coated prosthesis
US3685059A (en) * 1970-07-28 1972-08-22 Gulf General Atomic Inc Prosthetic blood circulation device having a pyrolytic carbon coated blood contacting surface
US3700380A (en) * 1970-10-01 1972-10-24 Tecna Corp Surface or lining compatible with blood or other tissue
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4173689A (en) * 1976-02-03 1979-11-06 University Of Utah Synthetic polymer prosthesis material
US4286341A (en) * 1979-04-16 1981-09-01 Iowa State University Research Foundation, Inc. Vascular prosthesis and method of making the same
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4323525A (en) * 1978-04-19 1982-04-06 Imperial Chemical Industries Limited Electrostatic spinning of tubular products
US4374669A (en) * 1975-05-09 1983-02-22 Mac Gregor David C Cardiovascular prosthetic devices and implants with porous systems
US4475972A (en) * 1981-10-01 1984-10-09 Ontario Research Foundation Implantable material
US4501263A (en) * 1982-03-31 1985-02-26 Harbuck Stanley C Method for reducing hypertension of a liver
US4503560A (en) * 1983-10-31 1985-03-05 Bourne I Stanley Chamois head cooler
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4544599A (en) * 1982-02-09 1985-10-01 Societe Europeenne De Propulsion Elastically deformable articles of carbon fibers, and method for producing the same
US4553545A (en) * 1981-09-16 1985-11-19 Medinvent S.A. Device for application in blood vessels or other difficultly accessible locations and its use
US4555771A (en) * 1978-08-31 1985-11-26 Fujitsu Limited Data processing system for data base management of matrix type data
US4562597A (en) * 1982-12-13 1986-01-07 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4604762A (en) * 1981-02-13 1986-08-12 Thoratec Laboratories Corporation Arterial graft prosthesis
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4678468A (en) * 1984-08-07 1987-07-07 Bio-Medical Co., Ltd. Cardiovascular prosthesis
US4712553A (en) * 1985-05-30 1987-12-15 Cordis Corporation Sutures having a porous surface
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4738740A (en) * 1985-11-21 1988-04-19 Corvita Corporation Method of forming implantable vascular grafts
US4768507A (en) * 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4786556A (en) * 1986-03-24 1988-11-22 Becton, Dickinson And Company Polymeric articles having enhanced antithrombogenic activity
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4816028A (en) * 1987-07-01 1989-03-28 Indu Kapadia Woven vascular graft
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4836884A (en) * 1986-02-17 1989-06-06 Telectronics N.V. Implantable materials
US4873308A (en) * 1988-09-30 1989-10-10 Medtronic, Inc. Biostable, segmented aliphatic polyurethanes and process therefor
US4879135A (en) * 1984-07-23 1989-11-07 University Of Medicine And Dentistry Of New Jersey Drug bonded prosthesis and process for producing same
US4878908A (en) * 1974-08-05 1989-11-07 Imperial Chemical Industries Plc Fibrillar product
US4878906A (en) * 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5019393A (en) * 1988-08-03 1991-05-28 New England Deaconess Hospital Corporation Biocompatible substance with thromboresistance
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5122154A (en) * 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5133742A (en) * 1990-06-15 1992-07-28 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5171262A (en) * 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5181903A (en) * 1988-03-25 1993-01-26 Duke University Method for improving a biomaterial's resistance to thrombosis and infection and for improving tissue ingrowth
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5197976A (en) * 1991-09-16 1993-03-30 Atrium Medical Corporation Manually separable multi-lumen vascular graft
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5219355A (en) * 1990-10-03 1993-06-15 Parodi Juan C Balloon device for implanting an aortic intraluminal prosthesis for repairing aneurysms
US5229431A (en) * 1990-06-15 1993-07-20 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses and the like
US5236447A (en) * 1990-06-29 1993-08-17 Nissho Corporation Artificial tubular organ
US5263992A (en) * 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US5266073A (en) * 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5290305A (en) * 1991-10-11 1994-03-01 Kanji Inoue Appliance collapsible for insertion into human organs and capable of resilient restoration
US5306286A (en) * 1987-06-25 1994-04-26 Duke University Absorbable stent
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material
US5336500A (en) * 1991-06-04 1994-08-09 Ecolab Inc. Sanitizing composition comprising a blend of aromatic and polyunsaturated carboxylic acid
US5354308A (en) * 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
US5356423A (en) * 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5385580A (en) * 1990-08-28 1995-01-31 Meadox Medicals, Inc. Self-supporting woven vascular graft
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5443499A (en) * 1993-01-14 1995-08-22 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5464450A (en) * 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5562724A (en) * 1993-12-15 1996-10-08 William Cook Europe A/S Endovascular graft prosthesis and an implantation method for such a prosthesis
US5575817A (en) * 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US5591228A (en) * 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5653747A (en) * 1992-12-21 1997-08-05 Corvita Corporation Luminal graft endoprostheses and manufacture thereof
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6302906B1 (en) * 1994-02-09 2001-10-16 Boston Scientific Technology, Inc. System for delivering a prosthesis
US6554858B2 (en) * 1996-04-25 2003-04-29 Corvita Europe Intraluminal endoprosthesis for ramifying the ducts of a human or animal body and method of manufacture thereof
US6843803B2 (en) * 1995-12-01 2005-01-18 Medtronic Vascular, Inc. Bifurcated intraluminal prostheses construction and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1205743A (en) * 1966-07-15 1970-09-16 Nat Res Dev Surgical dilator
EP0009941B2 (en) * 1978-10-10 1987-05-27 Imperial Chemical Industries Plc Production of electrostatically spun products
GB2115776B (en) * 1982-03-02 1986-03-12 Ontario Research Foundation Implantable material
DE3918736C2 (en) * 1989-06-08 1998-05-14 Christian Dr Vallbracht Plastic-coated metal mesh stents
EP0461791B1 (en) * 1990-06-11 1997-01-02 Hector D. Barone Aortic graft and apparatus for repairing an abdominal aortic aneurysm
US5161547A (en) * 1990-11-28 1992-11-10 Numed, Inc. Method of forming an intravascular radially expandable stent
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
AU669338B2 (en) * 1991-10-25 1996-06-06 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
AU8012394A (en) * 1993-10-01 1995-05-01 Emory University Self-expanding intraluminal composite prosthesis
AU1091095A (en) * 1993-11-08 1995-05-29 Harrison M. Lazarus Intraluminal vascular graft and method
NL9500094A (en) * 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.

Patent Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526005A (en) * 1967-06-29 1970-09-01 Gulf General Atomic Inc Method of preparing an intravascular defect by implanting a pyrolytic carbon coated prosthesis
US3685059A (en) * 1970-07-28 1972-08-22 Gulf General Atomic Inc Prosthetic blood circulation device having a pyrolytic carbon coated blood contacting surface
US3700380A (en) * 1970-10-01 1972-10-24 Tecna Corp Surface or lining compatible with blood or other tissue
US4878908A (en) * 1974-08-05 1989-11-07 Imperial Chemical Industries Plc Fibrillar product
US4374669A (en) * 1975-05-09 1983-02-22 Mac Gregor David C Cardiovascular prosthetic devices and implants with porous systems
US4459252A (en) * 1975-05-09 1984-07-10 Macgregor David C Method of forming a small bore flexible vascular graft involving eluting solvent-elutable particles from a polymeric tubular article
US4173689A (en) * 1976-02-03 1979-11-06 University Of Utah Synthetic polymer prosthesis material
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4323525A (en) * 1978-04-19 1982-04-06 Imperial Chemical Industries Limited Electrostatic spinning of tubular products
US4555771A (en) * 1978-08-31 1985-11-26 Fujitsu Limited Data processing system for data base management of matrix type data
US4286341A (en) * 1979-04-16 1981-09-01 Iowa State University Research Foundation, Inc. Vascular prosthesis and method of making the same
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4604762A (en) * 1981-02-13 1986-08-12 Thoratec Laboratories Corporation Arterial graft prosthesis
US4731073A (en) * 1981-02-13 1988-03-15 Thoratec Laboratories Corporation Arterial graft prosthesis
US4553545A (en) * 1981-09-16 1985-11-19 Medinvent S.A. Device for application in blood vessels or other difficultly accessible locations and its use
US4475972A (en) * 1981-10-01 1984-10-09 Ontario Research Foundation Implantable material
US4544599A (en) * 1982-02-09 1985-10-01 Societe Europeenne De Propulsion Elastically deformable articles of carbon fibers, and method for producing the same
US4501263A (en) * 1982-03-31 1985-02-26 Harbuck Stanley C Method for reducing hypertension of a liver
US4954126B1 (en) * 1982-04-30 1996-05-28 Ams Med Invent S A Prosthesis comprising an expansible or contractile tubular body
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4954126A (en) * 1982-04-30 1990-09-04 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4562597A (en) * 1982-12-13 1986-01-07 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4503560A (en) * 1983-10-31 1985-03-05 Bourne I Stanley Chamois head cooler
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4879135A (en) * 1984-07-23 1989-11-07 University Of Medicine And Dentistry Of New Jersey Drug bonded prosthesis and process for producing same
US4678468A (en) * 1984-08-07 1987-07-07 Bio-Medical Co., Ltd. Cardiovascular prosthesis
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4712553A (en) * 1985-05-30 1987-12-15 Cordis Corporation Sutures having a porous surface
US4776337A (en) * 1985-11-07 1988-10-11 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4776337B1 (en) * 1985-11-07 2000-12-05 Cordis Corp Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4738740A (en) * 1985-11-21 1988-04-19 Corvita Corporation Method of forming implantable vascular grafts
US4836884A (en) * 1986-02-17 1989-06-06 Telectronics N.V. Implantable materials
US4768507A (en) * 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4786556A (en) * 1986-03-24 1988-11-22 Becton, Dickinson And Company Polymeric articles having enhanced antithrombogenic activity
US4878906A (en) * 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5263992A (en) * 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US5306286A (en) * 1987-06-25 1994-04-26 Duke University Absorbable stent
US4816028A (en) * 1987-07-01 1989-03-28 Indu Kapadia Woven vascular graft
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US5266073A (en) * 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5181903A (en) * 1988-03-25 1993-01-26 Duke University Method for improving a biomaterial's resistance to thrombosis and infection and for improving tissue ingrowth
US5019393A (en) * 1988-08-03 1991-05-28 New England Deaconess Hospital Corporation Biocompatible substance with thromboresistance
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US4873308A (en) * 1988-09-30 1989-10-10 Medtronic, Inc. Biostable, segmented aliphatic polyurethanes and process therefor
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5171262A (en) * 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5229431A (en) * 1990-06-15 1993-07-20 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses and the like
US5133742A (en) * 1990-06-15 1992-07-28 Corvita Corporation Crack-resistant polycarbonate urethane polymer prostheses
US5236447A (en) * 1990-06-29 1993-08-17 Nissho Corporation Artificial tubular organ
US5122154A (en) * 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5385580A (en) * 1990-08-28 1995-01-31 Meadox Medicals, Inc. Self-supporting woven vascular graft
US5219355A (en) * 1990-10-03 1993-06-15 Parodi Juan C Balloon device for implanting an aortic intraluminal prosthesis for repairing aneurysms
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5356423A (en) * 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5336500A (en) * 1991-06-04 1994-08-09 Ecolab Inc. Sanitizing composition comprising a blend of aromatic and polyunsaturated carboxylic acid
US5197976A (en) * 1991-09-16 1993-03-30 Atrium Medical Corporation Manually separable multi-lumen vascular graft
US5464450A (en) * 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
US5290305A (en) * 1991-10-11 1994-03-01 Kanji Inoue Appliance collapsible for insertion into human organs and capable of resilient restoration
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5354308A (en) * 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
US5653747A (en) * 1992-12-21 1997-08-05 Corvita Corporation Luminal graft endoprostheses and manufacture thereof
US5443499A (en) * 1993-01-14 1995-08-22 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5562724A (en) * 1993-12-15 1996-10-08 William Cook Europe A/S Endovascular graft prosthesis and an implantation method for such a prosthesis
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US6302906B1 (en) * 1994-02-09 2001-10-16 Boston Scientific Technology, Inc. System for delivering a prosthesis
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5575817A (en) * 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5591228A (en) * 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US6843803B2 (en) * 1995-12-01 2005-01-18 Medtronic Vascular, Inc. Bifurcated intraluminal prostheses construction and methods
US6554858B2 (en) * 1996-04-25 2003-04-29 Corvita Europe Intraluminal endoprosthesis for ramifying the ducts of a human or animal body and method of manufacture thereof

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11439497B2 (en) 2001-12-20 2022-09-13 Trivascular, Inc. Advanced endovascular graft
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
US8298292B2 (en) * 2003-04-16 2012-10-30 Howmedica Osteonics Corp. Craniofacial implant
US20060224242A1 (en) * 2003-04-16 2006-10-05 Porex Surgical, Inc. Craniofacial implant
US20050288790A1 (en) * 2003-04-16 2005-12-29 Porex Surgical, Inc Craniofacial implant
US20100114316A1 (en) * 2003-04-16 2010-05-06 Porex Surgical, Inc. Craniofacial Implant
US7655047B2 (en) 2003-04-16 2010-02-02 Porex Surgical, Inc. Craniofacial implant
US8398720B2 (en) 2003-04-16 2013-03-19 Orthovita, Inc. Craniofacial implant
US20100070019A1 (en) * 2006-10-29 2010-03-18 Aneuwrap Ltd. extra-vascular wrapping for treating aneurysmatic aorta and methods thereof
US8709068B2 (en) 2007-03-05 2014-04-29 Endospan Ltd. Multi-component bifurcated stent-graft systems
US8317856B2 (en) * 2007-03-05 2012-11-27 Endospan Ltd. Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US20100063575A1 (en) * 2007-03-05 2010-03-11 Alon Shalev Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US11090148B2 (en) 2009-06-23 2021-08-17 Endospan Ltd. Vascular prosthesis for treating aneurysms
US8870938B2 (en) 2009-06-23 2014-10-28 Endospan Ltd. Vascular prostheses for treating aneurysms
US9918825B2 (en) 2009-06-23 2018-03-20 Endospan Ltd. Vascular prosthesis for treating aneurysms
US8979892B2 (en) 2009-07-09 2015-03-17 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US9757262B2 (en) 2009-07-15 2017-09-12 Endologix, Inc. Stent graft
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
US10888413B2 (en) 2009-11-30 2021-01-12 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US8945203B2 (en) 2009-11-30 2015-02-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US10201413B2 (en) 2009-11-30 2019-02-12 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US9572652B2 (en) 2009-12-01 2017-02-21 Altura Medical, Inc. Modular endograft devices and associated systems and methods
US9101457B2 (en) 2009-12-08 2015-08-11 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
US8956397B2 (en) 2009-12-31 2015-02-17 Endospan Ltd. Endovascular flow direction indicator
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US8858613B2 (en) 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods
US20150126997A1 (en) * 2010-10-20 2015-05-07 Medtronic Ardian Luxembourg S.A.R.L. Catheter Apparatuses Having Expandable Mesh Structures for Renal Neuromodulation and Associated Systems and Methods
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
US9486341B2 (en) 2011-03-02 2016-11-08 Endospan Ltd. Reduced-strain extra-vascular ring for treating aortic aneurysm
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
US8951298B2 (en) 2011-06-21 2015-02-10 Endospan Ltd. Endovascular system with circumferentially-overlapping stent-grafts
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9839510B2 (en) 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US9597204B2 (en) 2011-12-04 2017-03-21 Endospan Ltd. Branched stent-graft system
US20150005869A1 (en) * 2012-02-14 2015-01-01 Neograft Technologies, Inc. Kink Resistant Graft Devices and Related Systems and Methods
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US11000390B2 (en) 2012-06-15 2021-05-11 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US11779479B2 (en) 2012-06-15 2023-10-10 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US10195060B2 (en) 2012-06-15 2019-02-05 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US9132025B2 (en) 2012-06-15 2015-09-15 Trivascular, Inc. Bifurcated endovascular prosthesis having tethered contralateral leg
US10285833B2 (en) 2012-08-10 2019-05-14 Lombard Medical Limited Stent delivery systems and associated methods
US9415137B2 (en) * 2012-08-22 2016-08-16 Biomet Manufacturing, Llc. Directional porous coating
US11672886B2 (en) 2012-08-22 2023-06-13 Biomet Manufacturing, Llc Directional porous coating
US20140058526A1 (en) * 2012-08-22 2014-02-27 Biomet Manufacturing Corporation Directional porous coating
US10492913B2 (en) 2012-08-22 2019-12-03 Biomet Manufacturing, Llc Directional porous coating
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9737426B2 (en) 2013-03-15 2017-08-22 Altura Medical, Inc. Endograft device delivery systems and associated methods
US9044195B2 (en) 2013-05-02 2015-06-02 University Of South Florida Implantable sonic windows
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
US10485684B2 (en) 2014-12-18 2019-11-26 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US11419742B2 (en) 2014-12-18 2022-08-23 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US10610353B2 (en) * 2017-02-03 2020-04-07 Mayo Foundation For Medical Education And Research Methods for making nanofibrous coverings for implantable medical devices
US20180221146A1 (en) * 2017-02-03 2018-08-09 Mayo Foundation For Medical Education And Research Methods for making nanofibrous coverings for implantable medical devices
WO2018200972A1 (en) * 2017-04-28 2018-11-01 Regents Of The University Of Minnesota Compliant aortic stent grafts and related systems and methods
US11883273B2 (en) 2017-04-28 2024-01-30 Regents Of The University Of Minnesota Compliant aortic stent grafts and related systems and methods

Also Published As

Publication number Publication date
EP1342455A3 (en) 2004-07-28
EP1342455B1 (en) 2007-05-30
AU710862B2 (en) 1999-09-30
EP0883384B1 (en) 2000-12-06
ES2153600T3 (en) 2001-03-01
EP1342455A2 (en) 2003-09-10
ES2322893T3 (en) 2009-07-01
ATE197885T1 (en) 2000-12-15
DE69637839D1 (en) 2009-04-02
DK0883384T3 (en) 2001-02-19
EP1348403B1 (en) 2009-02-18
ATE422861T1 (en) 2009-03-15
DE29623953U1 (en) 2000-10-19
AU7529196A (en) 1997-06-05
EP1348403A3 (en) 2004-08-04
DE69611186D1 (en) 2001-01-11
JP3442081B2 (en) 2003-09-02
EP0883384A1 (en) 1998-12-16
CA2234976A1 (en) 1997-05-22
JPH11506034A (en) 1999-06-02
EP1348403A2 (en) 2003-10-01
DE69637115D1 (en) 2007-07-12
ES2287372T3 (en) 2007-12-16
EP1031331A2 (en) 2000-08-30
WO1997017913A1 (en) 1997-05-22
US5632772A (en) 1997-05-27
EP1031331A3 (en) 2000-11-15
CA2234976C (en) 2004-12-07
DE69637115T2 (en) 2008-01-31
DE69611186T2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
US5855598A (en) Expandable supportive branched endoluminal grafts
US5639278A (en) Expandable supportive bifurcated endoluminal grafts
US5632772A (en) Expandable supportive branched endoluminal grafts
US5948018A (en) Expandable supportive endoluminal grafts
US20080221668A1 (en) Expandable supportive branched endoluminal grafts
WO1997017913A9 (en) Expandable supportive branched endoluminal grafts
EP0874602B1 (en) Composite intraluminal graft
CA2236959C (en) Self-expanding endoluminal stent-graft
US6143022A (en) Stent-graft assembly with dual configuration graft component and method of manufacture
CA2397487A1 (en) Stent-graft with helically arranged securement member
AU736081B2 (en) Expandable supportive bifurcated endoluminal grafts
AU736766B2 (en) Endoluminal component with indent
MXPA99007689A (en) Bifurcated vascular graft and method and apparatus for deploying same

Legal Events

Date Code Title Description
AS Assignment

Owner name: CORVITA CORPORATION, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PINCHUK, LEONARD;ALCIME, RYSLER;KATO, YASUSHI;REEL/FRAME:019983/0536

Effective date: 20000818

AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORVITA CORPORATION;REEL/FRAME:029955/0866

Effective date: 20121220

AS Assignment

Owner name: LIFEPORT SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030003/0055

Effective date: 20121227